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SUMMARY
Human physiology shows a wide range of cyclical physiological changes co-
ordinated by endogenous biological clocks. These clocks work in different time
scales. Circadian rhythms follow the earth’s day-night cycle and have a period of
24 hours, while the ultradian rhythms have shorter periods. Multiscale changes
and variations in our physiology and behavior ensure optimal health and adap-
tation to our environment.
Disruptions in physiological rhythms have been shown to reflect illness, or
indeed, can lead to or exacerbate underlying conditions. For example, it has been
shown that the likelihood of suffering cardiovascular complications such as sud-
den cardiac death or arrhythmia is associated with the circadian rhythm [1]. This
may reveal a circadian mechanism of action. It is well-known that poor sleep can
lead to a variety of mental health issues [2]. Moreover, both physical and mental
health disorders (such as cardiovascular disease and depression) can lead to cir-
cadian disturbances, including difficulties falling asleep, nocturnal panic attacks,
and insomnia [3, 4]. This can create a reinforcement feedback loop to exacerbate
both mental and physical health issues.
Treatment of many disorders requires clinic visits, with a strong reliance on pa-
tient self-reports for filling in the gaps between these in-person assessments. This
lack of monitoring leads to both biases in the data (self-reporting/recollection is
well-known to be problematic [5]) and a lack of provision for responding to rapid
changes in health (such as cardiovascular decompensation or suicide risk). Ob-
jective tools for monitoring patients in between clinical visits are largely absent.
In recent years, advances in (and a push in commercialization) of wearable tech-
nology have enabled almost real-time monitoring of changes in physiology. This
has the potential to transform the landscape for monitoring diseases. However,
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despite these advances, there has been a general lack of rigorous studies ‘in the
wild’ and a lack of focus on novel metrics derived from the raw data.
The research described in this thesis aims to address the gap in the area of pas-
sive and continuous monitoring using wearables in naturalistic settings. Towards
this goal, the focus of this research is on building signal processing and machine
learning frameworks to quantify non-stationarities in physiological signals and
biological rhythm disruptions. In the first part of this dissertation, a wearable-
based sleep detection approach is developed. The proposed approach uses the
variations observed in the motion and heart rate data and detects patterns in
these change events associated with sleep-wake transitions. By combining differ-
ent modalities, this approach achieved higher wake detection accuracy compared
to a solely actigraphy-based method on a clinical cohort.
The second part of this dissertation focuses on features quantifying biologi-
cal rhythms to separate healthy controls and participants with health disorders
and validates the developed techniques in two different applications. The first
work presents the use of accelerometer and Photoplethysmogram (PPG) signals
to derive health outcomes post-trauma, based on analyzing circadian and ultra-
dian rhythm features with machine learning algorithms. Then, deep learning
algorithms are employed to extract features and representations for the same
classification task. The second work presents the use of both passive (motion,
location, social contact) and active (clinically-validated survey) data collected by
a smartphone app for monitoring HF patients non-invasively. The results show
that these data modalities could provide a complementary continuous monitoring
approach.
Once verified by deploying on devices in real-life settings, the tools in this
dissertation can potentially assist caregivers in monitoring patients and inform




Wearables could improve upon conventional long-term patient monitoring tools
because they can collect diverse and objective data types, provide insights into pa-
tients’ behavior in naturalistic settings, and capture biological rhythms over mul-
tiple time scales ranging from seconds to weeks. Treatment approaches for many
disorders are in-person clinic visits and monitoring patients with self-reported
questionnaires in between the assessments. However, varying symptoms might
not be captured in one hospital visit’s data [6], or might not reflect the patient’s
behavior in the home environment [7]. While administering questionnaires in the
gaps between the clinic visits aims to solve these problems, these self-reporting
tools are subjective and prone to recall bias [5]. Furthermore, some disorders may
require dynamic monitoring of changes to provide timely care and support. De-
veloping novel wearable-based monitoring methods would enable objective lon-
gitudinal assessments over multiscale physiological dynamics.
Biological rhythms occur on different time scales and have diverse cycle lengths.
The biological clock that follows the earth’s day-night cycle and has 24 hours pe-
riod is called the circadian rhythm [8]. The suprachiasmatic nucleus (SCN) of the
hypothalamus is the master clock that controls the circadian oscillators [3] and
regulates the synthesis of melatonin [9]. Therefore, the circadian master clock is
involved in orchestrating the timing and the structure of the sleep/wake cycle.
Ultradian rhythms result from various biological processes and have periods less
than 24 hours [10]. Some examples of ultradian rhythms include sleep states,
electrical activity changes in the brain, respiration, and circulation.
While the biological clocks are essential mechanisms for our survival and
1
adaptation to our environment, underlying adverse conditions could disrupt these
mechanisms. In the previous studies, it has been shown that physical and mental
health disorders could lead to circadian rhythm disturbances, including difficul-
ties falling or staying asleep, nocturnal panic attacks, or more severe symptoms
at particular times of the day [3]. While these circadian rhythm disturbances
are considered as symptoms of disorders, there is a bidirectional relationship,
and heightened circadian disturbances could exacerbate the symptoms of mental
and physical health issues [2]. Furthermore, it has been shown that cardiovas-
cular events such as cardiac death or arrhythmia demonstrate circadian rhythms
[1], and Heart Rate Variability (HRV) metrics follow circadian and ultradian cy-
cles [11]. Participants with Post-traumatic Stress Disorder (PTSD) show alter-
ations in the Hypothalamic-Pituitary-Adrenal (HPA) axis which regulates ultra-
dian rhythms, and therefore have an impact the cardiovascular system [12]. One
of the primary symptoms of the disorder is hyperarousal events, resulting in
sudden heart rate elevations. Consequently, studying the biological rhythm dys-
regulation over days as well as smaller timescales could provide novel insights
into both cardiovascular and mental health disorders and may widen our com-
prehension of their impact on physical health.
This dissertation describes the use of various data modalities from wearable
devices to build low-cost methods for passive monitoring. These methods can
complement conventional approaches (such as self-report questionnaires) and im-
prove the disease state estimation performance. In this work, wearable data is
analyzed in multiple timescales. On the ultradian scale, a novel sleep detection
technique was developed, and HRV metrics were derived. The circadian rhythm
was investigated using standard features and unsupervised machine learning ap-
proaches to generate novel features. Machine learning models were built to es-
timate or predict disease states from these features. Figure 1.1 illustrates some
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examples of ultradian and circadian cycles as well as the disease states. The up-
per plot shows the sleep/wake cycle, an ultradian rhythm occurring on an hourly
time scale. In the middle plot, daily changes in activity are shown to illustrate the
circadian rhythm. The bottom plot shows the disease states, which tend to move




















Figure 1.1: Biological rhythms and physiological states on three temporal scales.
1.1 Major contributions
The major contributions of this work can be summarized as follows:
• Designed and implemented a novel sleep/wake state detection method from
movement and physiological signals collected from wearable devices.
• Designed and implemented a machine learning-based algorithm for map-
ping motion and heart rate variability features that capture circadian and ul-
tradian variability from longitudinal wearable data to estimate post-trauma
outcomes.
• Developed a novel method for unsupervised feature extraction from 2-dimensional
representations of movement data using deep learning.
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• Designed and implemented a method for using passively collected smart-
phone data to predict heart failure decompensation events and developed a
novel late-fusion approach to fusing multimodal data.
The above contributions have been published in the following:
Journal articles:
• Siegel, B.I., Cakmak, A.S., Reinertsen, E., Benoit, M., Figueroa, J., Clifford,
G.D. and Phan, H.C., 2020. Use of a wearable device to assess sleep and
motor function in Duchenne muscular dystrophy. Muscle & Nerve, 61(2),
pp.198-204.
• Cakmak, A.S., Da Poian, G., Willats, A., Haffar, A., Abdulbaki, R., Ko, Y.A.,
Shah, A.J., Vaccarino, V., Bliwise, D.L., Rozell, C. and Clifford, G.D., 2020.
An unbiased, efficient sleep-wake detection algorithm for a population with
sleep disorders: change point decoder. Sleep, 43(8).
• Cakmak, A.S., et al. 2021. Classification and prediction of post-trauma
outcomes related to PTSD using circadian rhythm changes measured via
wrist-worn research watch in a large longitudinal cohort. IEEE Journal of
Biomedical and Health Informatics [in press].
Conference articles and abstracts:
• Cakmak, A.S., Reinertsen, E., Taylor, H.A., Shah, A.J. and Clifford, G.D.,
2018, December. Personalized heart failure severity estimates using passive
smartphone data. In 2018 IEEE International Conference on Big Data (Big
Data) (pp. 1569-1574). IEEE.
• Cakmak, A.S., Lanier, H.J., Reinertsen, E., Harzand, A., Zafari, A.M., Ham-
moud, M.A., Alrohaibani, A., Wakwe, C., Appeadu, M., Clifford, G.D. and
4
Shah, A.J., 2019. Passive Smartphone Actigraphy Data Predicts Heart Fail-
ure Decompensation. Circulation, 140(Suppl−1), pp.A15444-A15444.
• Cakmak, A.S., Thigpen, N., Honke, G., Alday, E.P., Rad, A.B., Adaimi, R.,
Chang, C.J., Li, Q., Gupta, P., Neylan, T., and McLean, S.A., 2020. Us-
ing Convolutional Variational Autoencoders to Predict Post-Trauma Health
Outcomes from Actigraphy Data. Presented at NeurIPS (Machine Learning
for Mobile Health), Dec 12, 2020 (online), also available as an arXiv preprint
arXiv:2011.07406. [Selected as spotlight presentation.]
The following article is currently in submission:
• Cakmak, A.S., Shah, A.J. and Clifford, G.D. Dynamics of interpersonal so-
cial interactions and motion passively captured from smartphones predict
decompensation in heart failure.
1.2 Scope and organization of the dissertation
This work is organized as follows: Chapter 2 presents background on sleep detec-
tion on wearables. Following this, PTSD, heart failure, and Duchenne muscular
dystrophy (DMD) disorders are described in detail. The chapter concludes with
detailed descriptions of the datasets used in this dissertation.
Chapter 3 focuses on variations on shorter time scales and ultradian rhythms.
The chapter summarizes change point detection techniques and assesses their
performance on artificial heart rate data. Then, a novel sleep detection tech-
nique that utilizes change points observed in physiological and movement sig-
nals from wearables is introduced. The technique’s performance was measured
on a dataset with simultaneous wearable, and Polysomnography (PSG) record-
ings from a sleep clinic and the expert annotations from the sleep clinic were
used as ground truth. The ability of the technique to accurately estimate sleep
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study parameters such as sleep efficiency was also assessed and compared to a
movement data-based approach. Finally, performance on a second dataset with
a second research watch was presented to demonstrate the generalizability of the
proposed technique to different devices.
Chapter 4 discusses the use of HRV and movement metrics from the research
watch for monitoring patients post-trauma passively. Previously validated and
novel features to quantify the ultradian and circadian variability are derived from
longitudinal watch data, and machine learning techniques are used to map these
to clinical outcomes. The second project discusses using an unsupervised deep
learning method to derive features from movement data and compare perfor-
mance with a fully supervised approach. Furthermore, sleep detection described
in Chapter 3 is applied to the data collected in daily living conditions to capture
the sleep disturbances post-trauma.
In Chapter 5, the analysis for intermediate and chronic disorders is presented.
In the first project, a smartphone-based framework is used to collect data for
heart failure patients. The HF decompensation event prediction ability of various
single-modality models are compared. It is shown that the late fusion approach
improves the performance of the models, and a time-to-event analysis is pre-
sented. In the following sub-sections, circadian rhythm metrics are derived from
movement data of intermediate and chronic state PTSD, and DMD patients and
relation to clinical outcomes are assessed. Finally, Chapter 6 discusses concluding




Smartphones and wearables become a part of our daily lives and give us an amaz-
ing opportunity to collect physiological data, in every part of the life and during
many human activities. In this part of the thesis, wearable-based methods for
sleep detection and disease state estimation (for post-traumatic stress disorder
and heart failure) are reviewed.
2.1 Sleep states and wearable-based sleep/wake detection
Several sleep/wake classification algorithms for wearables have been suggested
over the last decades, and they are typically based solely on actigraphy derived
from accelerometer [13, 14, 15, 16]. Several findings suggest that only using move-
ment signals leads to the main limitation of current algorithms: the incorrect clas-
sification and overestimation of low activity tasks as such sleep [17, 18, 19]. In-
deed, low activity (quiescent) segments are not unique to sleep but are common to
other activities such as reading or watching television. Another limitation results
from the adoption of imprecise evaluation metrics used in assessing the perfor-
mance of these devices. Since the percentage of sleep is typically higher compared
to wake overnight, total accuracy may not be a reliable metric to evaluate perfor-
mance. Sleep/wake detection may be considered as a “rare class problem” and
may be amenable to alternative model evaluation metrics which better reflect this
issue.
The first approaches in the field for state determination were based on cal-
culating a weighted sum over the actigraphy epochs around the current epoch
and scaling the summation to distinguish sleep from wakefulness [13, 14]. Oak-
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ley presented a similar approach in which the current epoch, epochs in the 2
minutes before and the 2 minutes after the current epoch are scaled with pre-
determined coefficients and summed [20]. If the summation is higher than the
threshold, the region was labeled as wake. The Oakley algorithm is utilized in
commercially available devices with different threshold selections (e.g., Actiwatch
2, Philips Respironics; Bend, Oregon). These actigraphic methods rely solely on
the amplitude of actigraphic signals, which makes them low cost and easy to
implement. However, these methods may overestimate sleep, particularly for pa-
tients with disordered sleep [21, 22]. It has been long been known that heart rate
reflects transitions from sleep to wake and from wake to sleep [23, 24, 25]. Re-
cent studies in the field leverage a combination of photoplethysmography (PPG)
and accelerometer signals for sleep/wake detection [26, 27, 28]. However, these
approaches have not been tested on clinical populations and still show low sensi-
tivity in detecting wake epochs.
2.2 Post-traumatic stress disorder
PTSD is a psychiatric condition that can develop after exposure to threatening
or horrifying events. Significant symptoms consistent with the eventual devel-
opment of PTSD may manifest within days, weeks or months, and more rarely,
a year or two after the traumatic event [29]. Symptoms may include persistent
intrusive memories of trauma, sleep disturbances, avoidance of stimuli related to
the trauma, hyperarousal, and negative changes in mood and cognition. PTSD
can result from events such as violent personal assaults, natural or human-caused
disasters, motor vehicle collisions, combat, and other forms of violence [30]. It has
been shown that patients with PTSD experience sleep disturbance, particularly in
terms of nightmares and panicked awakenings from sleep [4]. In addition, var-
ious studies suggest a significant comorbidity of pain with PTSD [31]. Many
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models have been developed to explain this co-occurrence of pain and PTSD, in-
cluding the mutual maintenance model [32]. According to this model, pain acts
as a reminder of the traumatic event and maintains PTSD symptoms. Then, these
symptoms reduce the ability to cope with pain effectively. Although approxi-
mately 90% of all U.S. adults report exposure to at least one traumatic event in
their lifetime, most do not develop PTSD [33]. It has been shown in previous
studies that the majority of individuals experience PTSD onset within the first
three months after trauma, while “delayed expression” PTSD (after six months)
was observed on average for 15.3% of the cases [34].
PTSD prediction using standard survey data remains a challenge, since po-
tential risk factors (such as age, gender, previous trauma) did not show a strong
association with PTSD [35, 36, 37]. In a previous study, Schultebraucks et al. [38]
combined biomarker data with clinical assessments from the emergency depart-
ment (ED) to build a cross-validated prediction algorithm. By fusing these two
modalities, the model’s Area Under The Curve (AUC) for classifying participants
with non-remitting PTSD symptoms from participants with resilient trajectories
was 0.83 on a validation dataset. They also tested the use of electronic medi-
cal records alone and achieved an AUC of 0.72, which outperformed the baseline
classifier (AUC=0.62). In another work, video and audio-based features were used
with a deep learning classifier and achieved an AUC of 0.90 for predicting PTSD
one month after ED enrollment [39].
The exponential increase in consumer wearables, and in wearable technology
generally, has created an exciting opportunity to predict adverse mental health
outcomes using wrist-wearable data [40, 41]. Two key outputs of wrist-wearable
data are HRV and actigraphic data. Individual differences in a various time- and
frequency-domain HRV measures have been found to predict a range of mental
and physical health outcomes, including depression, anxiety, and poorer cardio-
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vascular health [42, 43]. On the other hand, individuals with established PTSD
have been shown to have HRV profiles consistent with increased sympathetic
nervous system activity during sleep [44, 45]. In a previous pilot study, by using
a dataset of 23 subjects with current PTSD and 25 control subjects, the authors
found that HRV features derived from time periods with the lowest heart rate in
24-hour periods classify PTSD with an AUC of 0.86 [46]. McDonald et al. used
heart rate data from 100 participants to detect the onset of PTSD triggers [47].
By combining the heart rate features with and Support Vector Machine (SVM),
authors achieved an AUC of 0.67 and found that their algorithms associated the
increase of heart rate with onset of PTSD trigger.
Motion data provides a cost-effective solution for monitoring participants over
extended periods of time. It can be used to estimate sleep disturbance using de-
rived sleep/wake estimates and the rest/activity patterns [48]. Many studies
utilized actigraphy as an objective tool to characterize disturbances in sleep and
circadian rhythm in PTSD [49, 5]. However, analyses were confined to identifying
statistically significant differences in populations and cross-validated classifica-
tion analysis was not performed. In another study, Tsanas et al. developed a sleep
period estimation algorithm using accelerometer and ambient light data from
wearables [50]. Authors find that their proposed method can estimate the sleep
onset and sleep offset data captured by self-reported sleep diaries on a cohort
including 42 PTSD participants. In addition, they inspect the group differences
and found that the activity during sleep and Intradaily Variability (IV) features
to be statistically significant across groups. However, to author’s knowledge, no
other study has combined heart rate and motion data to build an objective multi-
variate classifier over extensive periods of time. This dissertation combines both




The American Heart Association estimates that between 2013 and 2016, approxi-
mately 6.2 million Americans had HF [51]. In 2012, the economic burden of HF
was estimated at $30.7 billion. Projections suggest a 127% increase in cost by 2030.
Overall, cardiovascular diseases account for the highest expenditures amongst all
non-communicable diseases in the US [52].
HF decompensation, associated with hypervolemia (volume overload), is de-
fined as a clinical syndrome in which a functional change in the heart leads to new
or increasing symptoms, including fatigue, dyspnea, and edema, and requires
hospitalization [53]. Treatment includes diuretics and vasodilators intended to
improve volume status and cardiac function. Unfortunately, even following suc-
cessful treatment and return to the euvolemic (normal volume status) state, de-
compensation episodes can continue to occur with increasing frequency [53, 54].
Patil et al. reported that about 20% of the patient cohort were readmitted within
30 days of initial hospitalization due to HF, with a median readmission time of 12
days [55]. Furthermore, patients with a lower income had a higher readmission
rate, indicating that socio-economical factors could also contribute to the disease’s
progression. If low-cost monitoring methods identify decompensation episodes
developing outside the clinic, medical interventions could be administered proac-
tively to prevent hospitalization or other adverse outcomes.
Various studies investigated techniques for monitoring HF patients non-intrusively.
Packer et al. [56] showed that using a combination of clinical variables and
impedance cardiography features could be a predictor of a decompensation event
in the next 14 days. Previous studies have also investigated the use of wearable
devices adhered to the chest. In the ‘Multisensor Monitoring in Congestive Heart
Failure’ study, the authors propose an algorithm that uses physiological signals,
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and they report a sensitivity of 63%, and specificity of 92% [57]. However, the
authors provide few details and claim it is ‘proprietary’. Inan et al. recorded
seismocardiogram signal with a non-invasive wearable patch before and after a
6-minute walk test to analyze the cardiac response to exercise [58]. The authors
used graph similarity scores between the rest and recovery phases and found a
significant difference between compensated and decompensated groups. In an-
other example, similarity-based modeling was used with physiological signals
from a patch on the chest to detect changes from the baseline. This algorithm
had a sensitivity of 88% and specificity of 85% [59]. Using ballistocardiogram
data recorded at home was also investigated [60], and authors demonstrated that
collecting high-quality ballistocardiogram data at home is feasible, and an AUC
of 0.78 could be achieved for classifying clinical status. Other non-invasive ap-
proaches include patient-reported outcomes, which could be collected using clin-
ically validated questionnaires such as KCCQ. The KCCQ assesses the quality of
life, predict readmissions and mortality in HF patients [61]. In a previous study,
Flynn et al. reported that KCCQ has modest correlations with exercise capacity
measured by the 6-minute walk test in a population with HF [62].
With the advancement of technology, smartphones have become a ubiquitous
part of our daily life. For long-term monitoring, using a smartphone could be
advantageous to a solution requiring an additional device by reducing the disrup-
tion to patients’ normal daily routine. Our research team and collaborators have
previously developed the Automated Monitoring of Symptom Severity (AMoSS)
app, which is a custom and scalable smartphone-based framework for remote
monitoring [63]. Subsequently, the current authors used the passive data from
the first ten participants of this study to estimate the KCCQ surveys collected
through the app [64]. The model estimated the KCCQ score with a mean abso-
lute error of 5.7%, providing an entirely passive method of monitoring HF related
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quality of life. (The method was passive in the sense that it does not require any
active participation by either the patient or clinical staff beyond the everyday use
of a mobile phone to monitor activity and behavioral patterns in the background
using software.) Then, in subsequent work, motion data was used to classify de-
compensation or compensation events [65]. By using a hold-out test randomly
sampled from 30% of the events (Ntest = 32), the AUC of the classifier was found
to be 0.76. Heart failure decompensation events were also predicted from fea-
tures derived from passive and active data collected by the smartphone-based
framework [66]. Features were extracted from multiple modalities including mo-
tion, social contact, location, and clinical survey data (KCCQ). Algorithms based
on using a single modality and two different sensor fusion approaches were de-
veloped. An analysis of the feature importance in the model is also presented.
Finally, a novel late-fusion model that combines the KCCQ, motion, and social
contact data is proposed.
2.4 Increased risk of cardiovascular disease due to post-traumatic stress disor-
der
PTSD has been associated with cardiovascular diseases and previous studies have
shown that PTSD might have harmful effects on cardiovascular health due to
following reasons:
• Physical changes: One of the main symptoms of PTSD include hypervigi-
lance, and the reminders of the traumatic event results in higher sympathetic
nervous system activity [12]. The activity of is sympathoadrenal axis is also
increased, and this leads to higher levels of catecholamine, which could ef-
fect the heart [67].
• Lifestyle factors: PTSD symptoms could lead to unhealthy behaviours in-
13
cluding smoking, alcoholism, or physical inactivity [68]. In addition, obesity
might also have an association with PTSD and patients with PTSD report
higher Body Mass Index.
Vaccarino et al. used a dataset of male twins from the Vietnam Era Twin
Registry to analyze the association of PTSD with coronary heart disease [12].
Authors found that the incidence of heart disease is double in twins with PTSD.
On another study, Kang et al. studied World War II prisoners of war, and found
that cardiovascular disease risk is significantly higher if participant has PTSD [69].
2.5 Duchenne muscular dystrophy
DMD is a genetic disorder that results in progressive loss of functional muscle
mass [70]. This progressive loss of muscle stats early in life and could result in
the loss of life in adolescent years due to compromise of respiratory muscula-
ture. Symptoms of DMD include gait abnormalities, difficulty rising up from the
ground, frequent falls, and sleep disorders [71, 72]. Previous studies have investi-
gated utility of actigraphy data to estimate outcomes related to DMD. Davidson et
al. used StepWatch activity monitor (Orthocare Innovations, Washington) to col-
lect data from participants with DMD (N=16) and healthy controls (N=13) [73].
By using parameters derived from the watch, authors found participants with
DMD had less step count and were inactive for longer periods. In another work,
22 participants with DMD wore an actigraph during their daily life [74]. The au-
thors found the area under the curve for each 1-minute epoch of actigraphy data
could be a useful feature to estimate the muscle strength. These works indicate
that wearable-based monitoring could be useful for DMD, but metrics related to
circadian rhythm have not been tested in this population yet.
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2.6 Datasets used in this thesis
2.6.1 Emory post-traumatic stress disorder dataset
The dataset in Emory PTSD study includes a subgroup of participants (n = 102,
men, mean age = 68.56, SD = 1.93) from the Emory Twin Study Follow-up re-
cruited from the Vietnam Era Twin Registry [75]. Written informed consent was
obtained from all participants, and the Emory University Institutional Review
Board approved this research (IRB #00081004). All PSG data were collected from
data acquisition systems (Natus, Remlogic) set up in two bedrooms in the Emory
Sleep Center. During PSG, subjects wore a commercially available wrist-worn
research watch (Empatica E4, Empatica; Cambridge, MA). The wrist-worn de-
vice recorded PPG and 3-axis accelerometer signals with sampling rates 64 Hz
and 32 Hz respectively. After the participants were discharged from clinic, they
start wearing Actiwatch research watch (Philips Respironics, Bend, Oregon). The
device collected activity data continuously everyday, up to two weeks and aggre-
gated into 30-second epochs.
2.6.2 Advancing Understanding of RecOvery afteR traumA post-traumatic stress
disorder dataset
The Advancing Understanding of RecOvery afteR traumA (AURORA) dataset,
used in this thesis, consisted of individuals who present to participating emer-
gency departments within 72 hours of a traumatic event [76]. Traumatic events
that qualified automatically for study enrollment were motor vehicle collision,
physical assault, sexual assault, fall > 10 feet, or mass casualty incidents. The
patients ranged in age from 18 to 75 years. Although the AURORA study’s aim
is to collect data from 5000 individuals, the data is being analyzed in a series of
tranches (or ‘freezes’) to report results to the scientific community. This approach
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also allows future data to act as a truly independent test set. For the current study,
we present the analysis of the first set of participants (N=1618) enrolled between
July 31, 2017, and July 31, 2019. There were 2312 subjects enrolled until July 31,
2019. Participants who were deceased, those who dropped, who were pregnant
or incarcerated, or anyone for whom the medical data extraction form was not
available were not included in the released analyzable cohort, making the final
dataset size 1618 participants. These 1618 participants are referred to as ‘Freeze 2’
dataset. Demographics (age, sex, BMI, and employment status) of the participants
are shown in Table 2.1.
Table 2.1: Freeze 2 dataset participant demographics. p values calculated using
Wilcoxon rank sum test (age, BMI) or Fisher exact test (sex, employment) between
PCL-5 ≥ 31 and PCL-5 < 31 participants. Age and BMI are shown as Mean (SD).













Age 35 (13) 36 (12) 35 (13) 0.31









The AURORA study protocol was ethically approved by the central Institu-
tional Review Board (IRB #17-0703) at the University of North Carolina Chapel
Hill. Participants were asked to wear a research watch (Verily Life Sciences; San
Francisco, CA) at least 21 hours a day for the eight-week period and at subse-
quent times that vary by the study participant. This research watch collected
accelerometry and the PPG data at 30 Hz sampling frequency.
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2.6.3 Automated Monitoring of Symptom Severity heart failure dataset
AMoSS app, designed and implemented by our research team and collaborators,
passively collects location, activity, clinical surveys and contact activity/diversity
data via de-identified lists of word type, as well as recipients and senders of
text messages and phone calls, including length/duration and time of day [77].
In order to protect subject’s privacy, all data are de-identified at source, using
hashed identifiers and random geographic offsets. The app uploads data every
few hours to Amazon Web Services for storage.
Subjects with HF were enrolled in an ongoing HF study at the Veterans Af-
fairs Medical Center and Emory University Hospital in Atlanta, USA. The study
protocol was approved by the IRB (#00075867) at Emory University. The AMoSS
app was installed on subject’s phone after they visited the HF clinic. The subject
could also opt to stop the collection of individual data types at any time. The app
passively collected data while the clinical team recorded the clinical events, which
consisted of hospital visits with compensated or decompensated status during the
enrollment.
Table 2.2: AMoSS HF dataset description. If the metric is not available, the partic-
ipant is excluded from that row.
Num. comp. events 62
Num. decomp. events 48
Avg. comp. events per person 2
Avg. decomp. events per person 2
Avg. ejection fraction (%) 35
Gender 93% male
Age (mean ± std) 67 ± 8






There were 28 participants (26 males) who contributed at least one clinical
event during their enrollment. To be included in the study, participants need to
have a diagnosis consistent with congestive heart failure as noted in the electronic
medical records within the Emory Health Network. Additionally, participants
needed to be over the age of 18, able to consent to a clinical study, and spoke
English as their primary language. Patients were ineligible for participation in the
study if they had been diagnosed with a terminal illness with a life expectancy of
less than six months or if they were enrolled in a hospice program. Additionally,
participants could not have been enrolled in clinical study that precluded them
from participating in another clinical study. Finally, participants had to be willing
and able to comply with the use of their smartphone as indicated in the study.
Table 2.2 shows more details about the participants in the dataset.
2.6.4 Duchenne muscular dystrophy dataset
Fifty five participants who were aged 5 to 17 years participated in the DMD study
conducted at Children’s Healthcare of Atlanta medical center. The study was
approved by Emory University Institutional Review Board. Participants were
recruited during regularly scheduled appointments. Informed consent was ob-
tained from parents or legal guardians, and assent was obtained from each par-
ticipant.
At the time of enrollment, 37 participants were taking steroids. Actigraphy
devices were provided for 31 participants. Nine did not wear the device at the
appropriate times or did not wear it at all. From the remaining 23 participants,
14 were ambulatory. During the study, each participant wore the Actiwatch 2
(AW2; Philips Respironics, Bend, Oregon) research watch for up to 10 days on
their non-dominant wrist. The research watch recorded data continuously each





CHANGE-POINT DETECTION FOR SLEEP STATE ESTIMATION
3.1 Rapid state change detection techniques
Non-stationarity is one of the key characteristics of human physiology and activ-
ity, driven by structured working days, alarms, unpredictable human interaction,
etc., as well as intrinsic changes in the central nervous and cardiovascular systems.
Many techniques have been proposed to artificially remove non-stationarities such
as ‘detrending’, or removing a mean, slope, or nonlinear fit in an arbitrary piece-
wise manner [78, 79]. However, such approaches tend to create large artifacts
around changes in stationarity [80, 81]. Moreover, many useful time series anal-
ysis techniques assume stationarity. Therefore, change point detection – the esti-
mation of points in time where the probability distribution of a stochastic process
changes – can enable the analysis of stationary segments of data and reveal under-
lying structure. For instance, Bernaola-Galvàn [82] used time series segmentation
and change point detection to investigate non-stationaries in human HR time
series and found mean level jumps between HR segments were smaller in heart
failure patients compared to healthy controls. Furthermore, HR interval segments
were found to follow a power law distribution, for both heart failure patients and
healthy controls.
In this work, six change point detection methods were applied to a realistic ar-
tificial dataset, which consisted of beat-to-beat (RR) interval time series data gen-
erated by a previously published model [83], hereafter referred to as “RRGen”.
The performance of each change point detection algorithm was evaluated as a
function of noise, tolerance (time between a true and estimated change point),
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and arrhythmia (ectopy). Using artificial data enables the assessment of algo-
rithmic performance by comparing estimated change points against true change
points. Moreover, if the artificial dataset is realistic, parameters of the change
point detection method can be optimized for use on real data that exhibits similar
statistics. By using the knowledge of the exact time of state transitions inherent
in RRGen, we tuned parameters of each algorithm to detect change points during
in real overnight recordings.
3.1.1 Artificial beat-to-beat interval time series data generation
The ‘RRGen’ algorithm was used to generate realistic 24-hour RR time series
(tachograms) from a model of cardiovascular interactions and transitions between
physiological states [83]. The model incorporates short-range variability due to
Meyer waves and respiratory sinus arrhythmia, and long-range transitions in
physiological states, by using switching distributions extracted from real data.
The model incorporates both short and long-term variability, modeled on the
normal sinus rhythm database [84]. Different tachograms can be produced by
calling RRGen with different seeds and one example is illustrated in Figure 3.1.
Figure 3.1: Artificial RR Interval data generated using RRGen. RR intervals are
shown as purple points and the true change points are shown with dashed black
lines.
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3.1.2 Change point detection methods
Recursive Mean Difference Maximization
Recursive Mean Difference Maximization (RMDM) was proposed by Bernaola-
Galvàn [82] to study scaling behavior of the human heart rate, and has been
tested on artificially generated non-stationary time series with different statis-
tical properties and real data [85, 86]. The method recursively maximizes the
difference in the mean values between adjacent segments. Given the input sig-
nal S = {x1, x2, ..., xN} of length N, a sliding pointer is moved from the left to
right, splitting the signal into S1 = {x1, x2, ..., xj} and S2 = {xj+1, xj+2, ..., xN} sub-
sequences with N1 and N2 number of samples respectively, where j is index at












The means are compared using the Student’s t-statistic:
t(S1, S2) =
∣∣∣∣∣ (µ1 − µ2)√σP
∣∣∣∣∣ (3.2)
where σP is the pooled variance, defined as
σP =
(N1 + N2)(V(S1) + V(S2))
((N1 + N2 − 2)N1N2
(3.3)
and V(S) is the sum of squared deviations of the data in the signal S:
V(S) = ∑
xi∈S
(xi − µ)2 (3.4)
Student’s t-statistic is calculated as a function of the index j in the time series.
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A candidate change point jmax is selected, at which t(j) reaches the maximum
tmax.
The significance level P(τ) of jmax is calculated as P(τ) = {tmax ≤ τ}, where
P(τ) could not be obtained in a closed analytical form and was numerically ap-








where γ = 4.19 ln N − 11.54, δ = 0.40, N is the length of the signal, ν = N − 1 is
the number of degrees of freedom, and Ix(a, b) is the incomplete beta function.
If P(τ) exceeds a predefined threshold P0 (0.95 as in this work), the signal is
split into two subsequences. Before index j is confirmed as a change point, τ be-
tween the two candidate subsequences is also calculated to see if the significance
exceeds P0. To reduce false positives, the condition that the minimum candidate
segment length should be greater than l0 was added. This procedure is repeated
for each new sub-sequence until splitting the signal into candidate subsequences
that differ by a significance level P0 is not possible.
Bayesian Blocks
This algorithm was proposed by Scargle et al. and detects change points via dy-
namic programming [87]. The Bayesian Blocks (BBlocks) approach fits a piecewise
constant signal model to data by maximizing a fitness measure specified accord-
ing to the data type.
The total fitness of the partition P of the signal S = {x1, x2, ..., xN} of length N











where Ns is the number of segments and f (Sk) is the fitness of the kth segment
Sk derived from maximizing the log likelihood of blocks given M point measure-







where xi is the ith data point and σi is the error variance of the data point mea-
surement. Note that in our case, since a data point’s measurement error was
unknown and the signal was normalized, the error variance was taken as σ = 1.
The BBlocks algorithm starts with a sub-signal of only one data point xi=1,
wherein only one segmentation is possible. In each step, a new datum xi=i+1 is
added to the signal and can be considered the last point of the last segment of a
possible optimal segmentation of samples. The starting point r of the last segment
of this optimal partition is obtained at each step by the following





where the definition of variables is the same as for the equations (Equation 3.6)
and (Equation 3.7) and P opt(r− 1) is the optimal partition from the previous step.
When the last data sample is presented to the algorithm, the calculated value
of rN becomes the last change point, marking the beginning of the last segment.
This segment is removed, the data point before rN is considered the last datum,
and the corresponding value of ri is assigned to the next change point. All change
points are found by starting from the end, moving towards the start of the time
series, and iteratively peeling off blocks.
Binary Segmentation
Binary Segmentation (BiS) has been widely used in change-point detection analy-
sis and is computationally fast ([88, 89]). The procedure minimizes a cost function,
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and starts by searching for a change-point τ in the input signal S = {x1, x2, ..., xN}
that satisfies the condition
CS1:τ + CS(τ+1):N + β < CS1:N (3.9)
where C is a cost function and β is a penalty term that reduces over-fitting.
If the condition in (Equation 3.9) is met, τ becomes the first estimated change-
point, and S1:τ and S(τ+1):n become the first subsequences. The process continues
within these segments until data cannot be divided any further. Cost function in
the above equation is given by
CSτi :τi−1 = −2 log L(θ|Sτi−1:τi) (3.10)
where L is the likelihood function. If the data is assumed to follow the Normal



















Any cost function C can be adapted for use in this framework, and one or more
change-points can be detected.
Pruned Exact Linear Time
This algorithm was proposed by Killick et al. [89] and minimizes a cost func-


















[C(S(τi−1+1):τi) + β]) + C(S(t+1):n) + β)
= min
t
(F(t) + C(S(t+1):n) + β)
(3.13)
Pruned Exact Linear Time (PELT) assumes that for all t < m < T, there is a
constant K that satisfies
C(S(t+1):m) + C(S(m+1):T) + K ≤ C(S(t+1):T) (3.14)
After each change point is estimated, pruning is performed by removing
points that satisfy the condition
F(t) + C(S(t+1):m) + K ≥ F(m) (3.15)
because these removed points cannot be the last optimal change point for T >
m. In this work, the built-in MATLAB r2019a function ’findchangepts.m’ was
used.
Bayesian Online Change Point Detection
Adams and MacKay proposed a Bayesian Online Change Point Detection (BOCPD)
algorithm [90] and further developed by Turner et al. [91]. This method estimates
change points using Bayesian inference, whereby the posterior probability of the
time since the last change point, referred to as “run length”, is calculated sequen-
tially.
For normally distributed data with unknown mean and variance, the conju-
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gate prior on observations follows a normal-inverse-gamma distribution with ν,
α, and β hyper parameters. On each step of the algorithm, a new datum xi=i+1
is added to the analyzed signal and xt indicates data sample at time t. The pos-
terior predictive probability of a new datum has the form of a non-standardized
Student’s t-distribution [92] with 2α degrees of freedom, center at µ, and PPV
αν
β(ν+1) .








Using predictive probability, growth probabilities are calculated as
P(rt = rt−1 + 1, x1:t) = P(rt−1, x1:t−1)π
(r)
t (1− H(rt−1) (3.17)
where H(τ) denotes the hazard function of a change point occurring. If inter-
vals between change points are assumed to follow an exponential distribution
with timescale λ, the hazard function becomes H(τ) = 1/λ. The change point
probability at time t is
















νt+1 = νt + 1,
αt+1 = αt + 0.5,




as defined in the conjugate Bayesian analysis of the Gaussian distribution [92].
This process repeats for the remaining data samples of the analyzed signal. After
the run length distribution is calculated for all samples, indices with maximum
probabilities are used to estimate the location of change points.
Modified Bayesian Online Change Point Detection Algorithm
Each new datum added to the analyzed signal results in one of two possible
events for the segment length rt: 1) it increases so rt = rt−1 + 1, or 2) a change
point occurs and rt = 0.
Originally, for each value of t, the run length probability vector v is sequen-
tially calculated. v(1) = P(rt = 0) is calculated by (Equation 3.18). v(2 : t) is the
probability of each possible run length at time t and calculated by (Equation 3.17).
This vector is normalized by (Equation 3.19). Finally, all run length probability
vectors are concatenated, and the run length with the maximum probability is
selected as the run length for time t.
Although the run length should drop to zero as a change point is encountered
in the time series, this approach fails to find rt = 0. Due to sequentially calculating
run length probability vectors, v(1) is rarely the maximum row in the vector, so
the run length is almost never set to zero.
A simple modification enables the correct selection of rt = 0 when change
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Figure 3.2: Top plot shows the artificially generated RR interval data, true change
points are shown in black dashed lines. Middle plot shows the run length for
BOCPD. Bottom plot shows the run length for mBOCPD. Note that the false trig-
gering of BOCPD algorithm is avoided using the mBOCPD algorithm.
points are encountered. The growth probability, e.g. probability of continuing the
current run, is calculated as




t )(1− H(rt−1)) (3.21)
The growth probability is compared to the change point probability P(rt =
0|x1:t). If the change point probability is higher, the segment is ended and the
run length becomes zero. Otherwise, the run length vector is increased by one.
This approach is illustrated in Figure Figure 3.2 and is denoted as the Modified
Bayesian Online Change Point Detection (mBOCPD) algorithm.
3.1.3 Performance metrics for change point detection
In order to assess how well estimated change points mapped to true change
points, the following performance measures were used:
• True Positive (TP): An estimated change point within a temporal tolerance
γ of a true change point was labeled as a true positive. If more than one
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estimated change point occurred within γ of a true change point, only one
estimated change point was counted towards the total number of true posi-
tives.
• False Positive (FP): If the estimated change point was not within the toler-
ance, γ, of any true change point, then it was labeled as a false positive.
• False Negative (FN): If there was not any estimated change point within the
tolerance γ of a true change point, then a false negative was recorded.
True negatives cannot be counted, since these would overwhelm any statistics
and depend heavily on the sampling frequency. The recall or true positive rate
(TPR = TP/(TP + FN)) and positive predictive value (PPV = TP/(TP + FP))
were calculated in this analysis. The true negative rate was not calculated be-
cause there were many more non-change points versus change points in the data.
Instead, the number of false positives was counted. Finally, the F1 score — the
harmonic mean of TPR and PPV (F1 = 2TP/(2TP + FP + FN)) - was used to
optimize the parameters of each algorithm.
3.1.4 Parameter selection for change point detection algorithms
To find optimal parameters for each algorithm, the F1 score was maximized via
grid search using realistic search ranges for each parameter. For RMDM, the
minimum segment length ranged from l0 = {6 : 1 : 12}. For BBlocks, the free
parameter ranged from γ = {1.5 : 0.5 : 4, 5}. After w0 and p0 was set, the optimal
posterior probability cut-off level was searched for in the range {0.5 : 0.1 : 1}. If
the posterior probability of a point was higher than that level, it was labeled as
a change point. In the analysis using the BOCPD method, the expected segment
length was tested in the range λ = {100 : 100 : 2000}. For mBOCPD, the expected
segment length ranged from λ = {10 : 10 : 100} for RRGen. PELT was tested
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via detecting changes in root mean square level, standard deviation, mean, and
“linear” mode – which finds the locations at which the mean and the slope of
the signal change most abruptly. For BiS, changes in mean or mean and standard
deviation were evaluated at the same time, and assumed data were drawn from
normal distributions. For Hannan-Quinn, BIC, and AIC information criteria, the
following penalties were tested respectively: β = 2p × log(log(N)), β = p ×
log(N), and β = 2× p. Parameters selected via grid search were used to analyze
artificial RR interval data, for RMDM a minimum segment length l0 = 7 was
used. For BiS changes based on mean were evaluated. For PELT changes were
based on root mean square level. For BBlocks a free parameter value γ = 4 was
used. For BOCPD, λ = 1840 was used and for mBOCPD an expected segment
length λ = 80 was used. Temporal tolerance γ was set to 10 seconds.
3.1.5 Change point detection performance on artificial beat-to-beat interval time
series
Figure 3.3: Performance of methods for detecting change points on the artificial
data.
Using RRGen, 500 samples of RR interval data of length 1000 samples were
generated. While RMDM achieved highest TPR when applied to artificial RR
interval data, BOCPD had higher positive predictive value and fewer false pos-
itive counts compared to other methods as shown in Figure 3.3. When artificial
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Figure 3.4: Performance of methods for detecting change points on the artificial
data with noise probability set to 0.1.
noise was added (probability of noise = 0.01), BiS achieved the highest positive
predictive value and the fewest false positive counts. The computation time (tc)
for methods was also recorded. For BOCPD and mBOCPD, tc was 0.178 and
0.164 seconds respectively. For RMDM tc = 0.159, for BiS tc = 0.129, for PELT
tc = 0.004, and for BBlocks tc = 0.023. When the length of artificial RR inter-
val time series was set to 9000 samples, the computational time was; for BOCPD
tc = 7.149, for BOCPD tc = 6.9146, for RMDM tc = 1.629, for BiS tc = 3.186, for
PELT tc = 0.010, and for BBlocks tc = 0.426.
3.2 A change point decoder for sleep-wake detection on memory-constrained
wearables
The Change Point Decoder (CPD) uses the change points from wearable device
signals to predict sleep or wake [93]. The method is inspired by the encod-
ing/decoding framework in neuroscience [94], where a neural population re-
sponse to a stimulus signal is observed in the form of spike trains. These re-
sponses are then used to train encoding models that describe the probability of
the responses. When a spike train is observed from a group of cells, this model
is used to ”decode” or estimate the stimulus signal. Similarly, in sleep/wake de-
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tection problems, the stimulus becomes the sleep/wake states, and alternations
in these states result in the observed changes in PPG and actigraphy signals. Pre-
vious studies have shown that the mean and standard deviation of heart rate
decreases during Non-REM sleep and increase during wakefulness [23, 24, 25].
We hypothesized that change point detection could be used to mark these alter-
ations in the heart rate. Body movements have also been used as a sleep/wake
identification feature in various studies over the years [13, 19, 20]. In this method,
changes in the amplitude and gross body movements were detected to capture
this information.
3.2.1 Preprocessing accelerometer and photoplethysmogram data
Initially, the Empatica E4 timestamp was synchronized with the PSG timestamp.
A series of preprocessing steps were applied to PPG and accelerometer signals
to convert these signals into a sequence of events. Firstly, the PPG signal was
preprocessed using PhysioNet Cardiovascular Signal Toolbox [95]. Peak detection
was performed using the qppg method provided with the toolbox, and the data
was converted to peak-to-peak (PP) interval time series. Then, non-sinus intervals
were detected and removed by measuring the change in the current PP interval
from the previous PP interval and excluding intervals that change by more than
%20. PP intervals outside of physiologically possible range were also removed to
obtain NN interval time series, which was filtered using a Kalman filter to reduce
noise [96, 97].
The accelerometer data was converted to activity counts following the ap-
proach by Borazio et al. [98]. Activity counts are the output format of most
commercial actigraphy devices; data are summarized over 30-s epochs or time in-
tervals. This conversion compresses information, and reduces required memory
for storing data. Z-axis actigraphy data were filtered using a 0.25–11 Hz passband
33
to eliminate extremely slow or fast movements [48]. The maximum values inside
1-s windows were summed for each 30-s epoch of data to obtain the activity count










































Figure 3.5: Preprocessing steps for the accelerometer data. Subplot (a) shows
the raw accelerometer data from z axis and subplot(b) is the data after filtering.
Activity counts obtained from summing the maximum values inside 1-second
windows are shown in subplot (c).
Lastly, a tilt angle time series was derived from the raw accelerometer data to
capture information that is not present in the activity count time series. Specifi-
cally, tilt angle, which is the angle between the gravitational vector measured by
the accelerometer and the initial orientation with the gravitational field pointing
downwards along the z-axis, can be calculated from the accelerometer reading as
ρ =
az√
a2x + a2y + a2z
(3.22)
where ρ is the tilt angle and ax, ay, and az are the readings from x, y, and z axes
of the accelerometer, respectively.
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After obtaining the NN interval, actigraphy, and tilt angle time series, change-
point detection techniques were applied to detect significant changes. We applied
BiS technique to NN interval and actigraphy time series [89]. In a previous study,
Yoneyama et al. stated that abdominal motion due to breathing causes 5° fluc-
tuations, so 10° threshold is ideal for detecting body turnover events [99]. 10°
changes in the tilt angle time series were stored as change events. In this way,
all signals were represented as event sequences of the form t1,i, t2,i, ..., tn,i where
n ∈ Z+ was the index of the change-point, i ∈ {1, 2, 3} was the type of time series
change-point occurred, and t ∈ R>0 denoted the time. Figure 3.6 illustrates the
conversion to event streams.












Figure 3.6: Conversion of NN interval, tilt, and actigraphy time series into point
processes. Left hand side figures show the signals and detected change-points
as dashed lines. Arrival times of each change-point tn,i are shown as dots in the
right hand side figures.
3.2.2 Encoding step
In the encoding step, following the approach by Pillow et al. [94], change-points
occurring in different signals were modelled. The intensity function λNN(t) for
NN interval time series was expressed as
λNN(t) = f (k · x(t) + h · zNN,history + cNN,act · zact + cNN,angle · zangle) (3.23)
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where x(t) was the sleep/wake stimulus that drives the changes in the signals.
k, h, c were stimulus, history, and coupling filters respectively. zNN,history repre-
sented the history of the Normal-To-Normal (NN) time series while zact and zangle
were the windows of actigraphy and angle time series. f was selected as the ex-
ponential function and it converted the summation into probability of spiking.
The process generating the event streams was viewed as a Poisson Generalized
Linear Model (GLM) and filter coefficients were estimated by fitting a GLM to
the data. This generalized linear model approach allowed for both excitatory and
inhibitory interactions between signals. We repeated same process for actigra-
phy and tilt angle time series to find the intensity functions λact(t) and λtilt(t)


















Figure 3.7: Encoding diagram for the angle time series. Raw signals from the
Empatica devices are converted to change-point time series. History, coupling,
and stimulus filters were applied on one-minute windows of data, summed and
converted to spiking probability of tilt angle time series in time interval ∂t using
instantaneous firing rate λtilt(t).
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Figure 3.8: Decoding sleep/wake states from change event streams. Top plot
illustrates the change events observed in NN interval, tilt and actigraphy time
series. These change events are decoded back into sleep/wake states, as shown
in the bottom plot.
3.2.3 Decoding step
In the decoding step, information about sleep/wake states was decoded back
from the patterns of change observed in the signals, as shown in Figure 3.8. The
log-likelihood function of events from a multidimensional process is given by






λi(t)dt + const. (3.24)
where θ = {k, h, c} represented model parameters from encoding step, x was the
sleep/wake stimulus, z was the event streams. The posterior probability of the
sleep/wake stimulus given the event streams was
log p(x|z) = log p(z|x) + log p(x) + const. (3.25)
Then, combining Equation 3.24 and Equation 3.25, penalized maximum likeli-
hood estimate of the sleep/wake stimulus was calculated by minimizing
xest = argmin
x
(− log p(z|x) + Λ‖xTV‖) (3.26)
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where xest was the estimate sleep/wake and z was the observed change event
streams. Total Variation (TV) norm prevented overfitting and preserved step-
like properties of the sleep/wake stimulus. After estimation, the output xest was
thresholded and converted back to binary sleep/wake detection.
3.2.4 Hyperparameter selection for change-point decoder
The data window size for encoding model filters, the TV regularization parameter
Λ, and the threshold were selected by sweeping a range of values and selecting
parameters maximizing the F1 score on the training set. The F1 score was used
to guide model selection since it is a combined metric for precision and recall. In
this task, precision indicates how many epochs in the detected wake are correct,
whereas recall refers to the percentage of total wake epochs correctly classified.
Therefore F1 score, which combines precision and recall, proves to be a useful
metric for this imbalanced classification scenario.
3.2.5 Performance on the Emory PTSD dataset
The Emory PTSD dataset was used for training and testing the proposed method
since in this study, participants underwent PSG study and wore their research
watch during the recording. The sleep technicians from the Emory Sleep Clinic
annotated the recordings and these annotations became the ground truth in the
analysis. The study population was assigned to four groups according to their
Apnea-Hypopnea Index (AHI) and Periodic Limb Movement Index (PLMI) as
follows:
• Group 1: Subjects with AHI < 15 and PLMI < 15
• Group 2: Subjects with AHI ≥ 15 and PLMI < 15
• Group 3: Subjects with AHI < 15 and PLMI ≥ 15
• Group 4: Subjects with AHI ≥ 15 and PLMI ≥ 15
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All the data from the dataset were randomly split into two sets, with 70 sub-
jects assigned to the training set and 32 subjects assigned to testing. Two-sample
Kolmogorov tests were performed for age, Apnea–hypopnea index (AHI), pe-
riodic limb movement index (PLMI), and sleep efficiency of the subjects in the
training and testing sets. Differences in these measures between the sets were
not statistically significant, suggesting that the training set is representative of the
testing set. Table 3.1 show ages and PSG-defined sleep efficiency in both sets.
Table 3.1: Participant Demographics and PSG Sleep Statistics in Training and Test
Sets from Emory PTSD dataset. Mean (Standard Deviation) of variables in each
group.







Group 1 19 68.11 (2.31) 75 (13) 9 68.22 (2.64) 74 (14)
Group 2 22 68.05 (2.03) 72 (14) 7 69.43 (1.62) 74 (13)
Group 3 24 68.42 (2.87) 74 (15) 14 68.28 (1.68) 67 (19)
Group 4 5 67.20 (3.42) 65 (16) 2 69 (0) 74 (5)
All Subjects 70 68.11 (2.48) 73 (14) 32 68.56 (1.93) 71 (16)
Hyperparameters selected on the training set for CPD are 1-minute window
size, regularization parameter of 2, and threshold3 of 0.22. Concordance between
PSG and the method was evaluated on the testing set. The mean across subjects
for total accuracy, sleep accuracy, wake accuracy, Cohen’s Kappa, F1 score, Wake
After Sleep Onset (WASO), and Sleep Efficiency (SE) were calculated. For both
WASO and SE metrics, the error was calculated as the PSG gold standard minus
estimated value. On the testing set, CPD achieved a total accuracy of 0.72, sleep
accuracy of 0.70, and wake accuracy of 0.74. Kappa value was 0.40, which indi-
cated fair agreement between the method and the gold standard PSG annotation.
WASO and SE errors were 7.66 minutes and 2.09 respectively.
Table 3.2 shows the same experiment repeated by using each signal by it-
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self, without the coupling filters between the different domains. Tilt angle signal
model performed better than PPG and actigraphy models in terms of Kappa, F1
score, WASO error, and SE error performance metrics. However, all three single
signal models resulted in lower total accuracy, Kappa, F1 score, and higher SE
error when compared to the combined model with the coupling filters.







Total accuracy 0.60 (0.14) 0.69 (0.13) 0.69 (0.15)
Sleep accuracy 0.49 (0.19) 0.89 (0.12) 0.65 (0.22)
Wake accuracy 0.83 (0.13) 0.34 (0.17) 0.75 (0.20)
Kappa 0.25 (0.17) 0.24 (0.19) 0.36 (0.23)
F1 score 0.60 (0.16) 0.41 (0.17) 0.61 (0.19)
WASO error (min) -53.31 (89.39) 65.13 (69.45) -2.44 (65.21)
SE error (%) 20.87 (22.37) -16.54 (15.98) 6.21 (18.13)
Comparison with other methods
The Oakley (OA) sleep/wake detection method was also implemented using the
same dataset. The algorithm is adapted for 30-second epochs following the ap-
proach by Kosmadopoulos et al. [100]. Actigraphy data is weighted and summed
as follows
Ai = 0.04 · E(i−4) + 0.04 · E(i−3) + 0.2 · E(i−2) + 0.2 · E(i−1) + 2 · E(i)
+ 0.2 · E(i+1) + 0.2 · E(i+2) + 0.04 · E(i+3) + 0.04 · E(i+4) (3.27)
where i denotes the current epoch index and E denotes the actigraphy count in
the epoch. Then Ai is compared to a predefined threshold to identify sleep/wake.
In Actiwatch devices, there are three different thresholds: low (20), medium (40),
and large (80). Since the wearable device is different in this study (Empatica E4,
40




Mean (SD) 95% CI
CPD
Mean (SD) 95% CI
Total Accuracy 0.76 (0.10) [0.73, 0.78] 0.76 (0.12) [0.73, 0.79]
Sleep Accuracy 0.82 (0.15) [0.79, 0.86] 0.78 (0.19) [0.73, 0.82]
Wake Accuracy 0.61 (0.19) [0.56, 0.65] 0.72 (0.18)* [0.67, 0.76]
Kappa 0.41 (0.17) [0.37, 0.45] 0.46 (0.20) [0.41, 0.50]
F1 Score 0.59 (0.14) [0.56, 0.63] 0.64 (0.15)* [0.60, 0.68]
WASO Error (min.) -22.82 (69.04) [-39.28, -6.36] 13.17 (56.84)* [-0.38 26.72]
SE Error (%) 3.01 (15.74) [-0.74, 6.76] -1.59 (14.18)* [ -4.97, 1.79]
* Wilcoxon signed-rank comparison of two methods, 5% significance level.
Abbreviations: CI, Confidence Interval; SD, Standard Deviation.
Empatica; Cambridge, MA), it could result in an actigraphy time series with a dif-
ferent amplitude range than Actiwatch and thresholds may not apply. Therefore,
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Figure 3.9: ROC and Precision-Recall curves for the CPD and OA methods. Per-
formance of both methods is illustrated as their threshold varied. Operating
points are shown with red circles on the plots.
Concordance between PSG and the two methods are evaluated on testing set.
The mean across subjects for total accuracy, sleep accuracy, wake accuracy, Kappa,
F1 score, WASO, and SE are shown in Table 3.3 and Table 3.4 for both methods.
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Mean (SD) 95% CI
CPD
Mean (SD) 95% CI
Total Accuracy 0.76 (0.09) [0.72, 0.79] 0.72 (0.14) [0.67, 0.77]
Sleep Accuracy 0.85 (0.12)* [0.80, 0.89] 0.70 (0.19) [0.63, 0.76]
Wake Accuracy 0.54 (0.20) [0.47, 0.62] 0.74 (0.21)* [0.66, 0.81]
Kappa 0.39 (0.17) [0.33, 0.45] 0.40 (0.24) [0.31, 0.49]
F1 Score 0.59 (0.14) [0.54, 0.64] 0.62 (0.20) [0.55, 0.70]
WASO Error (min.) -9.95 (63.75) [ -32.94, 13.03] 7.66 (67.34) [-16.62, 31.94]
SE Error (%) -0.03 (14.93) [-5.42, 5.35] 2.09 (16.81) [-3.97, 8.15]
* Wilcoxon signed-rank comparison of two methods, 5% significance level.
Abbreviations: CI, Confidence Interval; SD, Standard Deviation.
Figure 3.9 illustrates ROC curve and Precision-Recall curve for both methods as
their threshold is varied. Operating points selected using the training data are also
marked with red circles on the plots. The AUC for the CPD method was found
to be 0.78 and 0.67 for the OA method. Moreover, we observed from Figure 3.9
that it was possible to achieve similar performance to OA by changing the CPD
method’s threshold. However, it was not possible for OA method to reach the
CPD’s operating point by modifying the threshold value.
As shown in Table 3.3 and Table 3.4, the CPD method achieved greater accu-
racy for wake accuracy, Kappa, and F1 Score for both training and test sets. The
difference between wake accuracy was statistically significant (p < 0.05) for the
methods in both training and test sets. It can also be seen that OA overestimated
WASO while wake accuracy is low. Note that the CPD method exhibited lower
WASO error in both analyses. When using the medium threshold setting (40) is
used for the OA method, total accuracy was 0.54, sleep accuracy was 0.38, and
wake accuracy was 0.81 for the test set. The error in the number of sleep wake
transitions in the test set was overestimated as -17.19 (36.13) for the OA algorithm
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and underestimated as 64.41 (34.80) for the CPD.
Figure 3.10 provides the Bland Altman analyses of the differences for SE and
WASO for the OA and CPD methods for the Testing set. The modified Bland
Altman plot shows that the Oakley method exhibited a bias towards overestimat-
ing WASO (see Figure 3.10, bottom left subplot). These plots also show that both
methods exhibited similar performance as measured by SE error.
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Figure 3.10: Modified Bland–Altman plots for sleep metrics in test set. X-axis
shows ground truth (i.e. gold standard) PSG metrics and y-axis shows the differ-
ence between PSG and the estimates. Participants belonging to four subgroups
determined by AHI and PLMI are indicated with different symbols.
Table 3.5 and Table 3.6 compare the results of both methods for all four groups
in the test set. The CPD has a higher wake accuracy than the Oakley method in
each subject group, while the Oakley method performs slightly better in terms of
total accuracy.
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Group 1 Oakley 0.78 (0.07) 0.88 (0.10) 0.52 (0.20) 0.42 (0.13)CPD 0.76 (0.07) 0.76 (0.13) 0.73 (0.23) 0.44 (0.20)
Group 2 Oakley 0.78 (0.09) 0.84 (0.13) 0.55 (0.12) 0.42 (0.10)CPD 0.75 (0.12) 0.75 (0.13) 0.63 (0.27) 0.37 (0.30)
Group 3 Oakley 0.73 (0.09) 0.84 (0.13)
*
0.54 (0.25) 0.35 (0.20)
CPD 0.69 (0.18) 0.64 (0.23) 0.78 (0.18)* 0.39 (0.25)
Group 4 Oakley 0.75 (0.17) 0.78 (0.16) 0.67 (0.17) 0.44 (0.33)CPD 0.70 (0.14) 0.62 (0.21) 0.87 (0.02) 0.42 (0.21)
* Wilcoxon signed-rank comparison of two methods, 5% significance level.
Table 3.6: Sleep study statistic estimation per-






Group 1 Oakley -0.07 (18.75) -8.56 (78.67)CPD 1.67 (10.89) 5.33 (38.42)
Group 2 Oakley 0.71 (5.16) -16.00 (37.62)CPD -8.73 (14.38) 47.21 (72.94)
Group 3 Oakley -1.68 (16.93) -2.14 (69.85)CPD 5.54 (19.42) -1.04 (74.88)
Group 4 Oakley 9.02 (2.67) -49.75 (15.20)CPD 17.73 (13.65) -59.50 (53.74)
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Figure 3.11: Comparison of OA and the CPD methods for one participant in the
Emory PTSD dataset. First plot illustrates the activity counts from the Empatica
research watch, second plot shows the ground truth annotations from the Emory
sleep clinic. The third and fourth plots are the CPD and OA estimates respectively.
3.2.6 Performance on the data collected with Verily research watch
CPD method’s performance was also tested on the Verily research watch. Us-
ing the research watches from AURORA study, 21 nights were recorded from 3
participants. In this internal dataset, participants wore research watch while un-
dergoing a PSG study or wearing a Sleep Profiler (Advanced Brain Monitoring,
Carlsbad, CA). Ground truth labels for each night’s recording was obtained ei-
ther from sleep technician annotations for the PSG or Sleep Profiler. The CPD
model was not retrained due to the small size of this dataset but the weights from
Emory PTSD dataset was directly used. With threshold set at 0.5 level and no ad-
justment, sleep accuracy was 0.73, wake accuracy was 0.77, F1 score was 0.31, and
Cohen’s kappa value was 0.22. If the threshold is readjusted on this dataset using
the highest F1 score, sleep accuracy was 0.90, wake accuracy was 0.58, F1 score
was 0.43, and Cohen’s kappa value was 0.37. The data collection for this internal
study is still ongoing and the performance after retraining the model entirely will
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also be investigated in the future work.
3.2.7 Discussion
This chapter of the thesis presents a novel method (CPD) for identifying sleep and
wake states from movement and physiological signals collected using wearable
devices. The method was comprised of three types of filters; stimulus, history,
and coupling. Filter coefficients were estimated through a training process and
then were used to detect sleep and wake states from change points. Our approach
was flexible enough to incorporate various signal modalities and incorporating in-
formation from these results in higher wake detection performance. The CPD ap-
proach used a combination of movement-related and physiological signals, mak-
ing it possible to overcome some of the limitations of previous algorithms based
solely on actigraphy. For instance, the results demonstrate that the CPD method
does not overestimate sleep and has high wake detection performance. Therefore,
the CPD method can provide an unbiased solution to sleep/wake detection. The
CPD modeled time series of discrete change events derived from wearable device
signals and outputted a score of wakefulness which can be used to investigate
gradual transitions between sleep and wake states within the epochs.
The OA method exhibited a higher sleep accuracy with respect to the CPD
approach, which resulted in slightly higher total accuracy for OA since the preva-
lence of the sleep epochs in the data was relatively higher than the prevalence
of wake epochs. By contrast, we observed a significant improvement in wake
accuracy by using the CPD. Higher wake accuracy also resulted in lower WASO
error for both training and test sets with the CPD. The OA method overestimated
WASO and had lower wake detection accuracy, even though the threshold param-
eter was optimized during training (Table 3.3, Table 3.4). This outcome indicated
that the Oakley algorithm misclassified sleep epochs as wake while being unable
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to recognize true wake epochs. A similar pattern was observed in subjects with-
out any sleep disorder (Group 1) within the test set. This result could be due to
the fact that when there is no movement, OA could not estimate that the subject
was wake, as exemplified in Figure 3.11.
Periodic Limb Movement Disorder is characterized by episodes of limb move-
ments during sleep, and these limb movements could bias the actigraphy based
method into estimating a subject is awake. For Periodic Limb Movement Disorder
subjects (Group 3), the CPD method had higher wake accuracy compared to OA,
indicated in Table 3.5. However, this did not lead to significantly lowerWASO er-
ror due to the CPD method’s lower sleep accuracy in this group, suggesting that
limb movements had a similar effect in both methods.
Accurate estimates of WASO could become especially important in monitoring
populations with difficulties falling or staying asleep. For example, WASO dura-
tion has been used as a diagnostic criterion for insomnia [101]. The OA method
is known to have lower performance in detecting wakefulness for insomnia [21,
22]. In this study, optimizing the threshold parameter for OA did not yield a
significant increase in wake accuracy. Therefore, the CPD method could be more
useful in this population due to its higher accuracy in detecting wake epochs
and the lower error in WASO. On the other hand, CPD method had a high error
for estimating the number of sleep/wake transitions, which should be taken into
account while applying the method on the insomnia population.
The proposed method only required the timestamps of the change points. Due
to this fact, the CPD approach required less storage space than other methods. In
this study, saving raw accelerometer and PPG signals for each subject resulted
in 6.91 GB of data. However, if the change points alone were saved, stored data
were only 1.3 MB. Using the CPD method reduced the required memory to 0.02%
compared to other approaches that need the whole signal for feature extraction
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or training the models. As a result, the CPD method could result in immense
memory (and energy) savings for large populations, applications with more data
streams, and studies in which subjects are monitored over long periods.
This proposed method had some limitations. Since the signals were stored as
change point time series and raw signals were not saved, the information in signal
segments was lost. This could limit the data being used for other applications
such as detecting or monitoring disorders like arrhythmia or sleep apnea. Also,
it has been observed that the CPD approach has lower wake accuracy in subjects
with sleep apnea (Group 2) compared to other groups. Future studies will explore
adding a PPG-derived respiration signal to the model to improve performance in
subjects with sleep apnea. A second limitation of the CPD is the lower number of
sleep/wake transitions. The CPD method employs total variation regularization.
While this regularization prevents overfitting and preserves piecewise constant
structure of sleep/wake signal, it results in fewer switches between sleep and
wakefulness.
3.2.8 Conclusion
In conclusion, this work presents the Change Point Decoder, which is a novel
technique for sleep/wake identification in patients with highly disordered sleep.
The CPD provides higher wake detection accuracy when compared to a solely
actigraphy-based method. This superior performance could enable more accurate
investigation of the vital role of awakenings during the night in various psycho-
logical disorders. The CPD method requires low memory in the wearable devices
compared to existing methods, and therefore, it could prove beneficial in long-
term studies. Moreover, as a method, the CPD has the ability to adapt to different
and novel devices and signals beyond the accelerometer. In the following chap-
ter, features related to biological rhythms will be investigated and CPD will be
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CIRCADIAN RHYTHM DISRUPTION DETECTION
Acute diseases are health conditions that develop suddenly and have potential to
improve with correct treatments. In this chapter, the extent to which outcomes
developing post-trauma can be predicted from circadian rhythm changes was
investigated, using longitudinal data passively collected from a research watch.
Novel approaches to distinguishing between people that will and will not develop
PTSD after exposure to a trauma is presented using the AURORA dataset, which
was described in subsection 2.6.2. Figure 4.1 illustrates the AURORA study on












Figure 4.1: Illustration of AURORA study on disease time scales. The participants
are enrolled into the study after exposure to a traumatic event and monitored
through the acute phase using wearable devices.
The analysis in this chapter focuses on motion and heart rate data from the
accelerometer and PPG sensors of the research watch. Figure 4.2 and Figure 4.3
show the data contribution of participants over the monitoring period. In these
maps, if the participant did not share any samples from 1-hour window, it is
marked as missing. It can be seen that missingness of the motion data increases
gradually over time. On the contrary, heart rate data is missing from hour 10 to
20 consistently, possibly due to motion artifacts and low quality PPG data. For
instance, there were only 44 participants with less than 25% missing heart rate
data.
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Figure 4.2: Binary missingness map of the motion data for the AURORA dataset.
x axis is the 24 hours of the day, assuming the participant stayed in the same time
zone from the Emergency Department enrollment and ”0” hour is the midnight in
this time zone. y axis of the map shows each day. If the participant did not share
any samples from 1-hour window, it is marked as missing. Final map is obtained
by summing how many participants shared data for each 1-hour window across
56 days.













Figure 4.3: Binary missingness map of the heart rate data for the AURORA
dataset. The map is constructed following the same procedure described in Fig-
ure 4.2 for the heart rate data.
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4.1 Using circadian rhythm changes measured via wrist-worn research watch
for post-trauma outcome classification
The first method is based on a classification algorithm fed by a set of motion
features and HRV metrics. Data were analyzed using cosinor-based rhythmom-
etry method [102] to completely automate the detection of rest/activity periods
without the need for subjective information such as sleeping diaries or time zone
information in the setting of both complete and missing data (the latter resulting
from non-compliance or dead batteries). HRV metrics were extracted together
with actigraphy features to quantify rest and activity states and examined the
effect of varying the duration of data used to predict PTSD outcome.
4.1.1 Patient class labels and survey tools
Three clinical surveys were administrated in the ED – the Peritraumatic Distress
Inventory (PDI), PTSD Checklist for DSM-5 (PCL-5), and Michigan Critical Events
Perception Scale (MCEPS) [103, 104], as shown in Figure 4.4. PCL-5 administered
at the ED solicited information on symptoms 30 days prior to the traumatic event.
The raw scores of these surveys were used as features to the models to deter-
mine if prediction of the outcomes is feasible without using the research watch
data. Hereinafter, these surveys will be referred to as PDIED, PCL − 5ED, and
MCEPSED to indicate they were administrated at ED.
Three clinical surveys administered at the eighth week of the study were used
to create the binary outcome classes. These outcomes could potentially be used
to identify subjects who require intervention to prevent or reduce the severity of
PTSD. Firstly, the PCL-5 survey scores were used to capture PTSD symptoms out-
lined by Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria










Figure 4.4: Timeline of data collection and clinical surveys in the AURORA study.
dation of the developers of the PCL-5 survey [105].
Secondly, since patients with PTSD report sleep disturbance, the PCL-5 ques-
tionnaire was combined with one item from Pittsburgh Sleep Quality Index Ad-
dendum (PSQIA) in order to measure sleep anxiety and panic [49, 106, 107, 108].
This item is referred to as PSQIA-PanicSleep. The question and response cate-
gories were modified as follows to assess the difficulty of staying asleep: “In the
‘reference period’, how often did you awaken from sleep with severe anxiety or panic?” so
that 0 = “never”, 1 = “less than once a week”, 2 = “1-2 nights a week”, 3 = “3-4 nights a
week” and 4 = “every or nearly every night”. The cut-off for the survey was selected
in order to separate participants with severe sleep disturbance. In this outcome,
participants with PSQIA− PanicSleep ≥ 3 and PCL− 5 ≥ 31 were assigned to
the first class while PSQIA− PanicSleep < 3 and PCL− 5 < 31 were assigned to
the second class. This outcome is referred to as PTSD-Sleep Panic/Anx. outcome.
It has been shown in previous studies that chronic pain could accompany
PTSD [32]. For the third outcome, the PCL-5 survey was combined with Patient-
Reported Outcomes Measurement Information System (PROMIS) Pain Interfer-
ence Short Form 4a (PROM-Pain4a) [109]. In this survey, the participant was
asked to rate how much pain interfered with different areas of life on a 5-point
scale (1 = “not at all,” 2 = “a little,” 3 = “some,” 4 = “a lot,” and 5 = “extremely.”).
The same scoring rules as the PROMIS Pain Interference Short Form 4a scale was
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used; the response values were summed and converted to a T-score. The T-score
re-scales the raw score into a standardized score with a mean of 50 and a stan-
dard deviation of 10. A higher PROMIS T-score represents more of the concept
being measured and the T-scores help in interpreting the PROMIS scores in a
clinically meaningful way (More information about the T-scores could be found
in www.healthmeasures.net). By using the PROMIS T-score guidelines, the cut-
offs were selected for mild and severe pain interference following the guidelines
for T-score interpretation. Participants with PROM− Pain4a ≥ 66.6 (correspond-
ing to a raw score of 16) and PCL − 5 ≥ 31 were assigned to first class while
PROM − Pain4a < 55.6 (corresponding to a raw score of 8) and PCL − 5 < 31
were assigned to second. This outcome is referred to as PTSD-Pain Int. out-
come. Figure 4.5 illustrates the number of participants in each class, determined
by week eight outcome surveys. Hereinafter, these surveys will be referred to as
PSQIA− PanicSleepweek8, PCL− 5week8, and PROM− Pain4aweek8 to indicate they
were administrated at week eight.







































ED surveys and research watch →
Figure 4.5: AURORA Freeze 2 Dataset overview and number of participants in
each outcome group that is used in this research. Outcome surveys applied at
week eight (PCL-5, PSQIA-PanicSleep, and PROM-Pain4a) were used to create
the outcome groups. ED surveys included PDI, MCEPS and PCL-5 administrated
at ED department following trauma. Top row of the tables indicates the number of
participants that answered the outcome surveys, which is the maximum number
available for the analysis. The rows below the first row indicate if the participants
shared other modalities in addition to the outcome surveys.
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4.1.2 Preprocessing steps for the accelerometer and photoplethysmogram data
The raw sensor data collected by the Verily research watch was preprocessed
using the same procedure outlined in subsection 3.2.1. Movement data are com-
monly represented as a “double plot”, which shows activity levels (measured via
accelerometry in this case). Figure 4.6 illustrates this for one participant using
eight weeks of actigraphy data. Each column is created by stacking two consecu-
tive days of data. The first column shows activity levels on days 1-2, the second
column shows days 2-3, and so on. Darker colors indicate lower levels of activity.
If 24 hours are shown on the y-axis instead of 48 hours, we refer to this plot as
movement map.










Figure 4.6: Detection of rest and activity regions from actigraphy data. Lighter
colors indicate higher intensity movements. Deviations from the typical pattern
are seen on days 30-40 in this example participant.
Cosinor-based rest and activity region identification
Single-component cosinor models were used to detect 24-hour rest and activity
regions without any time-zone or sleep diary information [102]. Actigraphy data
of each participant were split into 48-hour windows with an overlap of 24-hours.
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The cosinor model with the following form was then fit to the data
Y(t) = M + K · cos(2πt/τ + φ), (4.1)
where M is known as the mesor, K is the amplitude, and φ is the phase of the
circadian rhythm. By identifying the times at which the cosine fit crossed the
mesor baseline, the start and end of rest and active segments of the day were
determined. The process is illustrated in Figure 4.7.
Figure 4.7: Fitting a cosine signal to actigraphy data to identify rest and activity
regions. Detected rest and activity regions are marked on the figure with black
and yellow shaded regions respectively.
4.1.3 Motion and heart rate variability feature sets
After preprocessing, the actigraphy signal in each 30-second epoch, together with
the NN interval time series of each participant, was used for feature extraction.
Table 4.1 and Table 4.2 describes the features extracted from these preprocessed
signals. Features derived from the accelerometer signal included Interdaily Stabil-
ity (IS), IV, the mean and standard deviation of movement in the detected rest and
activity regions, circadian rhythm strength, rest start index, and cosinor-based
rhythmometry metrics (Mesor, Amplitude, Phase).
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Table 4.1: Movement feature set, derived from the accelerometer data from the
Verily research watch.
Feature Name Abbr. Description
Interdaily Stability ISrest, ISact
The ratio between the variance of the
average actigraphy pattern around the
mean and the overall variance.
Intradaily Variability IVrest, IVact
The ratio of the mean squares of the
difference between all successive hours





Mean and standard deviation of movement




Average movement in active part of the day
divided by average movement in rest region.






Cosine fit to the data (described in Equation 4.1),
M is the mesor, K is the amplitude, and φ is the
phase of the circadian rhythm.
rest, act: Label indicating feature calculated during rest or activity periods
µ, σ: Mean and standard deviation across the days analyzed
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Table 4.2: Heart rate variability feature set, derived from the photoplethysmogram
data from the Verily research watch.
Feature Name Abbr. Description
Avg. NN Intervals NNmeanµ, NNmeanσ Mean of Normal-to-Normal (NN) intervals
IQR of
NN Intervals
NNiqrµ, NNiqrσ IQR of NN intervals
Kurtosis of
NN Intervals
NNkurtµ, NNkurtσ Kurtosis of NN intervals
Skewness of
NN Intervals
NNskewµ, NNskewσ Skewness of NN intervals
SDNN SDNNµ, SDNNσ Standard deviation of NN intervals
RMSSD RMSSDµ, RMSSDσ
Root-mean square differences of
successive NN intervals.
pNN50 pNN50µ, pNN50σ
Mean number of times per hour
in which the change in consecutive






Acceleration and deceleration capacity





Spectral content in high frequency band




Spectral content in low frequency band
(0.04Hz ≤ LF ≤ 0.15Hz)
Total Power ttlpwrµ, ttlpwrσ Sum of energy in all bands.
LF/HF Ratio LFHFµ, LFHFσ Ration of LF and HF power.
Sample Entropy SampEnµ, SampEnσ Sample entropy of NN intervals
Approximate Entropy
of Heart Rate
ApEnµ, ApEnσ Approximate entropy of NN intervals
Signal Quality Index avgSQIµ, avgSQIσ Morphology-based quality of each beat
µ, σ: Mean and standard deviation across the days analyzed
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A non-parametric way of quantitatively describing the rhythm is the Rest-
Activity metrics, which include IS and IV [110]. IS can be defined as the ratio of





where ā is the mean of all data, āh are the hourly means, ai are the data points,
and n is the number of data points in the interval. p is set to 24 for the circadian
rhythm assessment. IS quantifies the instability of the rhythm and the coupling
to the environmental zeitgebers such as light and temperature [111].
IV is the ratio of the first derivative to overall variance and quantifies fragmen-
tation of the rest-activity rhythm as
IV =
n×∑ni=2(ai − ai−1)2
(n− 1)×∑nh=1(ai − ā)2
. (4.3)
IV is a measure of the fragmentation of the rest-activity rhythm and it quantifies
the frequency of transitions between rest and activity. IV metric is higher if the
participant is taking naps frequently during the day or have frequent awakenings
during the night.
Rest-activity metrics have been used in various studies to assess the uncou-
pling of the rhythm to zeitgebers. In a previous work, we have derived the metrics
from smartphone data to estimate heart failure decompensation related symp-
toms which include worsening fatigue and edema [64]. Huang et al. used the
metrics to assess the age associated differences in circadian rhythm in a dataset
of 65 young, middle-aged, old and the oldest age group participants [112]. The
authors found that IV is highest in the oldest age group, which could indicate
sleep disturbances. Figure 4.8 illustrates one application of rest-activity metrics to
actigraphy data. It can be seen that a higher variation between each day results
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in a lower IS.
Figure 4.8: Movement patterns and rest-activity metrics for two participants. Sub-
plot (a) is the double plot of the first participant, subplot (b) is the average daily
activity, and subplot (c) is the plot of actigraphy data over hours. Subplots (d), (e),
(f) are the double plot, average daily activity, and actigraphy plot for the second
participant respectively.
Cosinor-based rhythmometry metrics can provide information about the par-
ticipants’ circadian rest-activity cycle [102]. To extract cosinor rhythmometry fea-
tures, a cosine model described in Equation 4.1 was fit to the data. M was mesor
(baseline activity of subject), K was amplitude (how active subject is during the
day versus night), and φ was acrophase (a metric of the circadian cycle).
In addition, average movement in the active part of the day was divided by
the average movement in the rest region to obtain the Circadian Rhythm Strength
(CRS) metric. Active and rest parts of the day were determined by using the
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approach described in subsubsection 4.1.2. Rest Start Index (RSI) was the hour
index of rest start region and approximated the start of the sleep period of the
day. Lastly, mean and the standard deviation of the movement data from the rest
active parts of the day was calculated (MV).
CRS, RSI, and cosinor-based rhythmometry metrics were extracted from each
day within the window and then the mean and standard deviation of the metric
were calculated. Similarly, for MV metrics, the mean and standard deviation of
12-hour rest and activity regions across the window were extracted.
The HRV feature set was derived using PhysioNet Cardiovascular Signal Tool-
box and included time domain, frequency domain and entropy metrics [95]. More
details about the HRV features used can be found in Table 4.2. Time domain fea-
tures included NNmean, NNiqr, NNkurt, NNskew, SDNN, RMSSD, and pNN50.
NNmean was the average heart rate without abnormal beats or arrhytmias. NNiqr
was the statistical dispersion of the NN intervals. NNkurt measured how peaked
or flat the distribution of the NN intervals was relative to a Gaussian. NNskew
quantified the asymmetry of NN interval distribution. Strong asymmetries could
be driven by rapid accelerations. SDNN reflected the cyclic components that
were responsible for variability. RMSSD was associated with short-term rapid
changes in the heart rate, and was correlated with vagus-mediated components
of HRV. pNN50 assessed parasympathetic (vagal) activity. Frequency domain
HRV metrics included HF, LF, ttlpwr, and LFHF. HF reflected the modulation
of vagal tone, primarily by breathing. LF reflected modulation of sympathetic or
parasympathetic tone by baroreflex activity. ttlpwr was the sum of energy in all
bands and was equivalent to variance. Lastly, LFHF was the ration of LF and HF
power and was indicator of sympathovagal balance. Entropy metrics included
SampEn and ApEn. SampEn quantified the likelihood that two sequences similar
for m points remain similar at the next point (i.e. match within a tolerance of r),
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not taking into account self-matches. ApEn quantified the amount of regularity
and the unpredictability of fluctuations over time-series data. In addition to these,
signal quality of the PPG signal was calculated and used as an additional feature.
All HRV metrics were calculated in 5-minute segments with a 30-second over-
lap using the toolbox. Then 5-minute segments from the rest regions, detected by
the cosinor method were selected in order to obtain the segments with the fewest
movement artifacts and highest signal quality. The mean and standard deviation
across the windows were calculated and used as features. Feature extraction was
performed on a virtual computer in AWS, (48 vCPUs, 3.6 GHz, 96 GiB memory)
and it took about three days for processing monthly data ( 700 participant’s data
on average).
4.1.4 Data organization for model training
As the first step in the pipeline, the data were adjusted by randomly undersam-
pling the majority class in order to address the problem of class imbalance. This
imbalance can be seen for PTSD-Sleep Panic/Anx. outcome, where the num-
ber of participants was 153 for the first class (PSQIA− PanicSleepweek8 ≥ 3 and
PCL− 5week8 ≥ 31) and was 613 for the second class (PSQIA− PanicSleepweek8 <
3 and PCL − 5week8 < 31). Specifically, all participants from the minority class
were used, and the same number of participants from majority class were ran-
domly selected to obtain balanced classes. Under-sampling of majority class sub-
jects was repeated in an external cross-validation fold, where n1 was defined as
the number of majority class participants and n2 was the number of minority class
participants. The external repeats were implemented n1/n2 times, and this ratio
was rounded to the nearest integer.
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4.1.5 Machine learning models
The mapping of the data or the normalized features (min-max normalization us-
ing [113]) into outcome classes is a supervised binary classification problem. All
the models were written in the Python 3 language and the programming code is
based on Scikit-learn [114]. Three different binary classifiers were trained for each
experiment category as follows:
• SVM: An SVM is a supervised model that is designed to find the optimal
separating hyper-plane with the maximum margin within the classes. Lin-
ear and radial basis function kernels were used.
• Logistic Regression: A logistic regression classifier uses a logistic function to
model the probabilities of the outcomes. L2 regularization was used with the
logistic regression classifier to achieve a robust model, minimize overfitting
and reduce any effect of codependences without reducing the number of
features. The regularization strength was set to the default level (1) of the
Scikit-Learn logistic regression classifier.
• Multilayer Perceptron (MLP): A MLP is a type of supervised classifier with
a feed-forward architecture, with one or more hidden layers between input
and the output. A one-layer MLP with 100 neurons and L2 regularization
was used, and these parameters were set at the default values for the Scikit
classifier.
A five-fold cross-validation procedure was used for parameter tuning and model
assessment and the class prevalence was adjusted to be identical in each fold.
The model was trained on the data from all participants except one held-out fold,
and the participants in the remaining fold were then used as the test data. This
process was repeated to ensure testing on all participants. Performance metrics
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were calculated for each test fold, and the mean and standard deviation of each
metric were calculated across the five folds. After extracting the features, the
training phase of the classifier took an average of 0.57 seconds on a 2.3 GHz i5
Intel chipset.
4.1.6 Overview of experiments
Three categories of experiments were performed as follows and all models were
tested for the full dataset and for the subset of participants whose PTSD outcome
at week eight is different from baseline PTSD status assessed in the ED (ex: PCL−
5ED < 31 and PCL− 5week8 ≥ 31):
• Experiment 1 (survey model): Prediction of eight-week outcome from ED
survey data. The PCL− 5ED solicits information on symptoms 30 days prior
to the traumatic event. The raw scores of these surveys were used as features
to the models.
• Experiment 2 (research watch model): Prediction of eight-week outcome
from the data. HRV and actigraphy features described in the previous sec-
tions were combined to obtain a feature matrix of 50 columns and models
were trained to predict or classify the single corresponding eight-week out-
come:
– Using all participants and using a 56-day window.
– Prediction of eight-week outcome using 7, 14, . . . , 56 days of HRV
and actigraphy features, using participants who contributed data on
all days. When an analysis window shorter than 49 days was used,
the classifier was “predicting” the outcome at day 56 “ahead-of-time”.
However, when the analysis window size was 56 days for example, it
reduced to a “classification” task.
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– Analysis of feature trajectories (daily averages of each feature in the
56-day window): Participants who report as non-PTSD (PCL − 5ED ¡
31) in ED were isolated. Two subgroups were then created by looking
at week eight surveys; participants who develop new-onset PTSD and
those who remain non-PTSD. Then, the significance of each feature for
these subgroups was tested using the Wilcoxon rank sum test.
• Experiment 3 (fusion model): Fusion of research watch and survey models
by concatenating the feature sets. Experiment 3 was implemented on par-
ticipants who contributed both the research watch data and the ED survey
data. Survey model and research watch model from previous experiments
were also trained on this subset of participants to ensure results are directly
comparable and the contribution of fusing modalities could be tested accu-
rately.
4.1.7 Experimental results
Results of Experiment 1
The cross-validation performance of different types of classification models using
ED survey-based features is shown in Table 4.3. Logistic regression classifier has
achieved the highest AUC for all outcome types. Table 4.4 shows all metrics in-
cluding accuracy, TPR, TNR, and PPV for the logistic regression classifier. Models
showed high performance for all outcome types; 0.67, 0.70, and 0.70 accuracies for
PTSD, PTSD-Sleep Anx./Panic, and PTSD-Pain Int. outcomes respectively.
The performance was evaluated for the participants for whom PTSD outcome
changed from admission to week eight (N=270 for PTSD outcome, N=150 for
PTSD-Sleep Anx./Panic outcome, N=110 for PTSD-Pain Int. outcome) without
retraining the model. For these subsets of the participants, accuracies of 0.33,
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Table 4.3: AUC comparison of different classifiers using ED surveys as features
for eight-week outcome prediction. Results are reported as mean (standard devi-
ation).
Outcome Log. Reg MLP RBFSVM
Linear
SVM




0.79 (0.04) 0.79 (0.05) 0.76 (0.07) 0.78 (0.07)
PTSD,
Pain Int. 0.77 (0.04) 0.77 (0.04) 0.74 (0.04) 0.76 (0.04)
Table 4.4: Performance of logistic regression model using ED surveys as features
for eight-week outcome prediction (N=739 for PTSD outcome analysis, N=468 for
PTSD-Sleep Anx./Panic outcome analysis, N=326 for PTSD-Pain Int. outcome
analysis). Results are reported as mean (standard deviation).
Outcome Acc. AUC TPR TNR PPV




0.70 (0.06) 0.79 (0.04) 0.67 (0.11) 0.74 (0.07) 0.72 (0.07)
PTSD,
Pain Int. 0.70 (0.04) 0.77 (0.04) 0.68 (0.03) 0.73 (0.09) 0.72 (0.09)
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0.32, and 0.34 was achieved for PTSD, PTSD-Sleep Anx./Panic, and PTSD-Pain
Int. outcomes respectively.
Results of Experiment 2
Table 4.5 shows the performance of different classifiers when HRV and actigraphy
features were used. It can be seen that similar to Exp. 1, logistic regression classi-
fier performed the best for all outcome types. Models achieved the highest AUC
of 0.70 and accuracy of 0.65 when the outcome is PTSD-Pain Int. However, the
performance was lower for other outcome types; accuracy was 0.56 for PTSD out-
come and 0.58 for PTSD-Sleep Anx./Panic. Table 4.6 shows the logistic regression
classifier performance in detail for the research watch models. The model per-
formance was similar for participants undergoing a change in the clinical status.
The accuracies were 0.55, 0.59, 0.64 for PTSD, PTSD-Sleep Anx./Panic, and PTSD-
Pain Int. outcomes respectively for this subset. For each outcome type, Figure 4.9
shows the feature importance determined by the absolute value of the logistic
regression coefficients, averaged over folds. Figure 4.10 illustrates the AUC from
each window size when participants with data contribution from all 56 days are































































Figure 4.9: Feature importance for logistic regression models (window size=56
days). Highest five average absolute feature coefficients across folds are illustrated
for each outcome
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Figure 4.10: AUC of the logistic regression models with different window size
selection. Subplot (a) shows the AUC for the PTSD outcome, subplot (b) shows
PTSD-Panic Sleep/Anx. outcome, and subplot (c) shows PTSD-Pain. Int. outcome
over the days
Table 4.5: AUC comparison of different classifiers using HRV and actigraphy fea-
tures for eight-week outcome prediction. Results are reported as mean (standard
deviation).
Outcome Log. Reg MLP RBFSVM
Linear
SVM




0.61 (0.06) 0.60 (0.06) 0.61 (0.07) 0.59 (0.06)
PTSD,
Pain Int. 0.70 (0.02) 0.69 (0.04) 0.69 (0.03) 0.69 (0.02)
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Table 4.6: Performance of logistic regression model using HRV and actigraphy
features for eight-week outcome prediction. Results are reported as mean (stan-
dard deviation).
Outcome Acc. AUC TPR TNR PPV




0.58 (0.05) 0.61 (0.06) 0.64 (0.07) 0.53 (0.08) 0.58 (0.08)
PTSD,
Pain Int. 0.65 (0.04) 0.70 (0.02) 0.69 (0.04) 0.63 (0.08) 0.65 (0.08)
Results of Experiment 3
For comparison with the fusion models, experiments were repeated on the par-
ticipants who contributed both research watch and survey data. The AUC was
improved for participants whose PTSD status has changed, in all outcome types
compared to the ED survey only models. For PTSD outcome AUC improvement
was two percentage points. For PTSD-Sleep Panic/Anxiety outcome, improve-
ment was six percentage points, and for PTSD-Pain Int. outcome improvement
was 26 percentage points. The AUC of the overall model (including all partici-
pants) was also improved to 0.79 for PTSD-Pain Int. outcome type as shown in
Table 4.7. However, for all outcome types, AUC of survey and fusion models were
not significantly different as determined by Hanley and McNeil two-tailed test.
Table 4.7: AUC comparison of different model types. Results are reported as
mean (standard deviation).
Model PTSD PTSD-SleepAnx./Panic PTSD-Pain Int.
Survey 0.74 (0.03) 0.77 (0.07) 0.75 (0.09)
Research watch 0.54 (0.04) 0.55 (0.08)* 0.68 (0.04)
Fusion 0.73 (0.04) 0.75 (0.09) 0.79 (0.04)
* Table entry corrected to show the result for PTSD-Sleep
outcome.
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4.2 Change-point decoder sleep detection performance on the AURORA dataset
CPD method described in section 3.2 was also applied to AURORA dataset. One
of the challenges in applying sleep detection methods to wearable data collected
in-the-wild is accurate detection of the sleep period. If the sleep period is detected
accurately, it could be used to estimate metrics related to sleep. For example,
sleep efficiency is the ratio of total sleep time to the sleep period and it requires
knowledge of both the sleep period length and the sleep/wake estimate during
the sleep period. Asking the participants to fill sleep diaries is one method of
recording sleep periods in research studies [115]. However, this technique could
be subjective as it requires the participant to input sleep onset and offset times
and this procedure was not was not used in AURORA study. In addition, Verily
research watch did not record time zone information. Therefore, two different
methods to estimate the sleep period were tested. For the first method, the rest
periods obtained by fitting a cosine (described in detail in subsubsection 4.1.2)
was used as the sleep periods. For the second method, the time zones of par-
ticipant’s ED visit during the enrollment was recorded. It was assumed that the
participant stays in this timezone during the entire study period. After the de-
tection of sleep periods, the data within each period was used for sleep detection
and sleep feature estimation.
The data from each sleep period was converted to change-points. Then, CPD
method was applied to change event time series. As described in subsection 3.2.6,
the model was not retrained and the weights obtained from the Emory PTSD
dataset was used directly. Two different features were calculated to quantify the
sleep disturbance. Sleep efficiency (SE) was used to quantify how well participant
slept. The number of sleep/wake transitions (SWNum) was calculated to assess
the frequency of episodes of wakefulness and sleep disturbance.
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To assess the severity of sleep disturbance, a slightly modified version of the
Insomnia Severity Index was administered at week eight of the study [116]. Lower
scores indicate no clinically significant insomnia while higher scores indicate se-
vere clinical insomnia. Participants who had contributed at least more than three
sleep periods were determined and by using this questionnaire, the participants
with severe insomnia were assigned to the first class (N=82) while the remaining
participants were assigned to the second class (N=411). Majority class was ran-
domly under-sampled to obtain balanced classes. The mean, standard deviation,
and the slope of sleep features (SE, SWNum) were calculated from the 14-day
window before the Insomnia Severity Index questionnaires. A logistic regression
model with L1 regularization was built to estimate the outcome classes deter-
mined by the questionnaire. Five-fold cross validation was used to validate the
model.
Table 4.8: Performance of sleep outcome prediction models. Results are reported
as mean(standard deviation) of the external folds of each experiment.
Sleep period
estimation technique Acc. AUC TPR TNR PPV
Cosinor-based 0.54 (0.05) 0.58 (0.06) 0.57 (0.13) 0.51 (0.09) 0.52 (0.04)
ED time zone 0.59 (0.06) 0.61 (0.08) 0.60 (0.09) 0.58 (0.16) 0.58 (0.08)
Table 4.8 shows the performance of the models for week eight outcome pre-
diction when different sleep period estimation techniques are used. The ED time
zone based sleep period model achieved 11% better performance compared to the
baseline and these results indicate that this technique holds promise to quantify
the sleep disturbance of the participants. It can also be seen that the performance
depends on the selection of sleep period estimation technique.
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4.3 Unsupervised feature extraction using convolutional variational autoen-
coders
Deep learning methods could learn meaningful representations from the actig-
raphy data. Furthermore, unsupervised learning is well suited for this problem
space because the data without the labels derived from clinical surveys could be
utilized. This research represents the first attempt to apply unsupervised deep
learning methods to actigraphy data for feature extraction and representation.
The outcomes of three clinical surveys were used to create the classes for the
binary classification experiments. The Post-traumatic Stress Disorder Checklist
for DSM-5 (PCL-5) was used to measure PTSD symptoms and participants with
PCL-5 score greater than 28 were labeled as PTSD [117]. Scored depression vari-
ables from PROMIS Depression - Short Form 8b (PROM-Dep8b) were used to
measure depression symptoms, with a threshold of 60 for depression [118]. One
item from Pittsburgh Sleep Quality Index Addendum [108] (“how often did you
awaken from sleep with severe anxiety or panic”) was used to assess the diffi-
culty in staying asleep (PanicSleep). In the first experiment, the PCL-5 survey
was used by itself, while in the second experiment, PCL-5 and PanicSleep survey
scores were combined to determine the outcome classes. Lastly, all three surveys
were combined to find the participants who experienced both depression and
PTSD symptoms. Also, the participant’s general physical health status in the 30
days pre-trauma was used as a feature to test if it could increase the performance
of models based on passive actigraphy data. This pre-health score is a derived
normative score based on questions from the 12-Item Short Form Health Survey
(SF-12) [119].
In the experiments, all participants from the minority class were used, and
the over-represented majority class was under-sampled so that the results were
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not biased due to the unequal class prevalence. For the deep learning models,
internal 5-fold cross-validation was performed. All experiments were repeated 30










































































































Figure 4.11: (a) Daily actigraphy levels for one participant, this double plot shows
activity levels measured over 28 days. (b) CNN-LSTM model, movement data
with 24-hour time steps are used as inputs to time distributed 1-D CNN layers.
(c) VAE model, latent features were used with a logistic regression classifier for
outcome prediction. VAE was also used to generate artificial movement data to
train the CNN-LSTM model.
A variational autoencoder (VAE) is an unsupervised generative model that has
an encoding phase in which the input data is projected onto lower-dimensional
latent representations and a decoding phase that reconstructs the input, as shown
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in Figure 4.11 (c). However, in the VAE model, the encoder is trained under the re-
striction that the latent representations follow a Gaussian distribution N(Zµ, Zσ).
In this work, unlabelled movement maps were used to train a convolutional VAE
with two 2D convolution layers (Conv2D) with 16 and 32 number of filters and
kernel sizes of 3. The number of units in the dense layers was set to 16. The num-
ber of filters in the Conv2DTranspose layers were 32, 16, and 1. The embedding
dimension of VAE was 8. The model was trained for 30 epochs with a batch size
of 128. Then, the latent representation of the movement maps (zact) was used as
input features to a logistic regression model in binary classification experiments.
Secondly, an alternative supervised CNN-LSTM model was trained to esti-
mate mental health outcomes from clinical surveys. The number of filters in the
Conv1D layer was set to 32, and the kernel size was 3. The number of units
in the LSTM and the dense layer was set to 20. Actigraphy data were inputted
as 24-hour subsequences, and the model was trained for 30 epochs with a batch
size of 32. Lastly, 100 healthy and 100 unhealthy artificial movement maps were
generated with VAE models by using randomly sampled encoding vectors. The
artificial data was used in the training step of the CNN-LSTM model to test if the
performance will be improved.
We visualized what the different VAE latent representations learned by plot-
ting their traversals as shown in Figure 4.12.
We observed that when the unsupervised features extracted with the VAE
model were combined with the physical health before the traumatic event (cap-
tured with the SF− 12), the model achieved an AUC of 0.64 and an accuracy of
0.60 in differentiating healthy participants from participants showing PTSD and
depression symptoms as determined by clinical surveys. When model was re-
duced to passive data only (by removing the SF− 12 feature), the AUC dropped












Figure 4.12: Latent traversals of pre-trained VAE model. Each row reconstructs an
movement map as the value of each latent dimension is traversed between [-2, 2]
while keeping the values of all other latent variables fixed. Most of the variables
show decreasing of daily energy, while z8 shows the circadian phase change.
to identify participants with PTSD and sleep disturbance, as shown in Table 4.9.
The CNN-LSTM model had an accuracy of 0.56 and an AUC of 0.57 in classifying
healthy participants and participants showing PTSD and depression symptoms.
By incorporating the artificial data generated by the VAE, the recall of the model
increased from 0.45 to 0.60, while other metrics did not change.
Table 4.9: VAE model mental health outcome estimation performance. Results are
reported as mean(standard deviation) of the external folds of each experiment.
Outcome Features Acc. AUC Precision Recall
PCL-5 zact 0.55(0.01) 0.56(0.01) 0.55(0.01) 0.51(0.01)
PanicSleep
PCL-5










0.60(0.02) 0.64(0.03) 0.61(0.02) 0.57(0.03)
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Table 4.10: CNN-LSTM model mental health outcome estimation performance.
Results are reported as mean(standard deviation) of the external folds of each
experiment.
Outcome Features Acc. AUC Precision Recall
PCL-5 zact 0.52(0.01) 0.53(0.01) 0.53(0.02) 0.40(0.04)
PanicSleep
PCL-5




zact 0.56(0.04) 0.57(0.04) 0.58(0.05) 0.45(0.08)
4.4 Comparison of models using movement data
In order to directly compare all approaches for the movement data (feature ex-
traction, VAE-based feature extraction, and CNN-LSTM), the movement features
from subsection 4.1.3 were used to estimate the same outcomes as the deep
learning methods. This movement data based feature set included ISrest, ISact,
IVrest, IVact, MVrest,µ, MVrest,σ, MVact,µ, MVact,σ, CRSµ, CRSσ, RSIµ, RSIσ, Mesorµ,
Mesorσ, Amplitudeµ, Amplitudeσ, Phaseµ, Phaseσ and more details about each fea-
ture could be found in Table 4.1. For PTSD outcome, model performed slightly
above random chance (Acc.=0.53 and AUC=0.55) similar to previous analysis. For
PTSD-Sleep Panic/Anx. outcome, the model achieved an accuracy of 0.60 and an
AUC of 0.62. For PTSD-Pain Int., accuracy of the model was 0.59 and the AUC
was 0.64. On the other hand, when the VAE-logistic regression approach was
run to estimate the PTSD-Pain outcome the accuracy was 0.52, AUC was 0.53. In




In this part of the dissertation, features and patterns related to ultradian and cir-
cadian rhythmicity derived from data recorded on a research watch were used to
predict or detect post-trauma outcomes. Patients with PTSD have previously re-
ported sleep disturbance symptoms including insomnia and nightmares [49]. Pre-
vious studies have also shown that PTSD has a high co-occurrence with chronic
pain, which could interfere with patients’ daily lives [31, 32]. Moreover, PTSD
could also result in decreased interest in activities, as stated by the DSM-5 cri-
teria [30]. Therefore, we hypothesized that PTSD might lead to changes in the
biological rhythms that could be captured by the actigraphy and HRV data.
In the first project, three clinical surveys administered in the ED were used as
features to train a logistic regression model to predict eight-week PTSD. Using
these ED surveys, the models achieved AUCs of 0.73 for PTSD outcome, 0.79 for
PTSD-Panic Sleep/Anx. outcome, and 0.77 for PTSD-Pain. Int. outcome. These
results indicate that previous PTSD status and stress experienced immediately
following the traumatic event are a significant predictor of PTSD in the following
months. However, in general, these models predicted that the PTSD status is
unlikely to change.
Then, the use of various types of machine learning models with HRV and
actigraphy features was investigated. The logistic regression model achieved the
highest cross-validated accuracy for predicting the PTSD label at week eight post-
trauma when the data from the enrollment until the end of week eight was con-
sidered. The weights of the logistic regression model were analyzed to identify
the contribution of each feature Figure 4.9. NNiqrσ, avgSQIµ, LFµ and LFHFµ
had the highest relative importance amongst the HRV features. LF power, in par-
ticular, was lower in the population with eight-week PTSD (a mean of 1178ms2 vs
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1562ms2). Since the LF power is dominantly associated with baroreflex activity,
it can be interpreted as blunted baroreflex activity over this period [120], which
is consistent with the literature on PTSD [121]. Previous studies have also shown
that LF power is significantly different in stressful conditions compared to the
resting conditions [122, 123]. Therefore, this metric could be reflecting the stress
the participants are experiencing following the traumatic event. From the actig-
raphy based metrics, the movement during the rest and the active parts of the
day, IVact, ISrest, ISact and CRSσ, metrics were the most important. IV measures
the fragmentation of rest/activity rhythm and the transitions between rest and
activity, and IVact shows irregular activity during the daytime. IS is a measure
of variability between days [124]. ISrest and ISact were informative when the out-
come is PTSD-Sleep Anx./Panic. This result could indicate that anxiety resulting
from trauma could lead to decoupling from zeitgebers in both rest and activity
regions.
It is debatable whether collecting data from surveys or a wearable (such as our
research watch) represents a lower burden for subjects who develop PTSD. Wear-
able technologies such as smartwatches (and even mobile phones) are now com-
monplace and provide the opportunity to collect data without user intervention,
while survey-based assessments are active data collection techniques requiring
effort and input from the user. However, wearables also require frequent device
charging at regular intervals, which is unsustainable in the long term unless a
user already is in the habit of doing so. It may not be an either/or proposition,
though, and these two approaches could complement each other. For example,
participants who were not able or willing to fill in the survey at admission could
benefit from passive data collection. In our study, N = 533 participants did not
fill the ED surveys, but they wore research watches. For these participants, watch-
based models could become the prime monitoring method. However, compliance
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could also be affected by diagnostic status. Research watch data compliance was
calculated as the hours with data divided by total hours in the eight-week win-
dow, and it was significantly different in PTSD-Sleep Panic/Anx. groups as de-
termined by the Wilcoxon rank sum test. Average compliance was 83% for the
first group (PanicSleep ≥ 3 and PCL− 5week8 ≥ 31) and was 86% for the second
group (PSQIA-PanicSleep < 3 and PCL − 5week8 < 31). The compliance to ED
surveys (PDI, MCEPS, PCL− 5ED) was higher for PCL− 5week8 ≥ 31 group (69%)
compared to PCL− 5week8 < 31 group (48%), and this difference was statistically
significant as determined by the Fisher exact test. The research watch models
could be more useful for participants undergoing a change in clinical status since
the data analysis is windowed and can provide a daily or weekly output which
may be interpreted as the severity of illness. This could facilitate the evaluation
of response to intervention, for example. Therefore, watch-based models have the
potential for passive monitoring over long study periods.
The cosinor method described in this work for determining the rest and activ-
ity regions could be helpful for the studies in which participants across different
time zones or in situations when obtaining sleep diary and time zone informa-
tion would be highly burdensome for the participant. In the second sub-project,
these rest regions were used as the sleep periods, and sleep-related metrics were
derived from the data within the periods by applying CPD sleep detection tech-
nique. However, the model achieved only slightly better performance than ran-
dom chance (AUC=0.58) to detect severe sleep disturbance. In comparison, time
zones recorded during the ED enrollment were assumed to be the time zone
participants were located, and then CPD was applied to the 6-hour window af-
ter midnight. This second technique performed better (AUC=0.61) compared to
cosinor-based rest period detection, indicating the importance of sleep period es-
timation method selection. However, in both cases, the performance of estimating
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the self-reported insomnia outcome was low. This finding is consistent with pre-
vious research [5, 125], and could indicate that self-reported insomnia does not
match the objective estimates for the PTSD patients.
In the third sub-project, unsupervised learning was leveraged, and it was
shown that the VAE model could extract more informative features and achieved
higher accuracy compared to the CNN-LSTM. VAE approach compresses four-
week worth of actigraphy data into an 8 dimensional vector. Therefore, this
method could result in immense memory savings for applications with more
data streams or long-term studies and could be adapted to different and novel
devices. Finally, the performance of the deep learning models and machine learn-
ing models with hand-extracted features were compared using the motion data.
By looking at the results, it can be seen that estimating the PTSD outcome based
on only PCL-5 survey is difficult for all models. The performance was better when
somatic symptoms such as sleep or pain are included, and hand-crafted features
perform slightly better compared to deep learning-based approaches. As more
data is collected, the training of deep learning methods could be improved.
There are several limitations to this work. First, the outcomes (PTSD status at
week eight) may reflect the appearance of PTSD at any time over the intervening
eight weeks. The high variability in the speed of development of PTSD is likely
to create high class confusion in any machine learning paradigm. Moreover, there
is the potential for individuals’ PTSD symptoms to wax and wane over eight
weeks, further confusing any algorithm trained on such data. Second, due to the
use of self-report surveys from week eight for constructing outcome classes, our
cohort is a subset of the original AURORA Freeze 2 dataset, albeit a rather large
cohort. As more data are collected in the AURORA study in the coming years, we
will address this limitation by re-evaluating the methods with more participants.
Lastly, time zone information was not available for our participants. Circadian
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(mis)alignment may have provided additional information for adjusting features.
While the cosinor-based rest-activity detection might compensate for this lack of
information, it cannot fully address the issue.
4.6 Conclusion
In this chapter, various approaches to quantify ultradian and circadian rhythms
are presented. This research represents, to best of the author’s knowledge, the
first attempt to predict outcomes following a traumatic event from a wearable (or,
more specifically, a research watch). Outcomes were both classified and predicted
using non-invasive physiological features derived from the research watch, using
a logistic regression model. A method to automatically detect rest and activity
periods of the day was also developed using the cosinor analysis and combined
with CPD method to estimate sleep metrics. Activity heat plots were used for
unsupervised feature extraction for the first time using deep learning methods.
Acute conditions could lead to chronic conditions without the required treat-
ment and they also have the capacity to improve with early detection of symp-
toms. For example, accurate prediction of PTSD in the early aftermath of trauma
would enable early preventive interventions [126]. Rothbaum et al. [127] showed
that trauma survivors receiving an early modified prolonged exposure interven-
tion reported significantly less PTSD severity compared to the assessment group.
It has also been shown in a preliminary study that administering an early single
high-dose hydrocortisone could reduce the risk of PTSD development [35]. While
wearable-based PTSD detection based on only PCL-5 survey was not very effec-
tive, the performance was very promising when other somatic symptoms such
as sleep disturbance or pain was included in the outcome classes. Notably, the
model for participants with a combined PTSD and pain outcome combined pro-
vides the highest performance. Identifying and treating these particular types
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of individuals is extremely important. Previous studies report that patients with
both chronic pain and PTSD combined use healthcare services more than the pa-
tients with PTSD or chronic pain alone, increasing healthcare costs [32]. Moreover,
PTSD treatment for these patients could be more beneficial than for other groups,
since they also report a reduction in pain symptoms after treatment [128].
In conclusion, the methods for classifying or predicting outcomes (for window
sizes smaller than 49 days) could be useful in passively monitoring changes in
symptom severity in large populations and in low-resource settings. Without the
prior knowledge of which patients to administer treatment to, smartwatch-based
monitoring could be used to identify the subset of patients to prioritize.
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CHAPTER 5
CHRONIC DISEASE STATE PREDICTION
Chronic diseases are health conditions that are persistent and last long periods
of time with reoccurring symptoms [129]. In this part of the thesis, the signal
processing and machine learning techniques for chronic disease state prediction is
presented. Using the dataset described in subsection 2.6.3, features were derived
from passive and active data collected by the smartphone-based framework for
predicting or classifying heart failure decompensation events. The movement
data from research watches in DMD and Emory PTSD studies were also analyzed
in relation to clinical outcomes. Figure 5.1 shows the datasets used in this part of














Figure 5.1: Illustration of AMoSS, DMD and Emory PTSD studies on disease time
scales.
5.1 Methods for monitoring heart failure patients using passive smartphone
data
5.1.1 Data collection using the smartphone application and the clinical events
Figure 5.2 illustrates the study timeline and the data collection after the enroll-
ment and discharge from the clinic. We analyze different data modalities, includ-
ing motion, social contact, location, and clinical survey data (KCCQ) collected by
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the smartphone. We develop algorithms based on using a single modality and
two different sensor fusion approaches. We also present an analysis of the feature
importance in the model and report a novel late-fusion model which combines











Figure 5.2: Illustration of the AMoSS HF study timeline. Passive data collection
started after the hospital discharge, and the clinical team recorded the clinical
events after the enrollment.
Clinical events
Clinical events consisted of decompensated and compensated events and were
collected by the clinical team when the participants visited the hospitals. In the
compensated events, the participants visited the hospital for any reason, and their
fluid levels were determined to be normal. For the decompensated events, the
clinical team determined the participant to have functional limitation related to
HF. Decompensated and compensated events were assigned to positive and neg-
ative classes respectively. The number of events contributed by each participant
varied as shown in Figure 5.3.
Passive data sources
The raw 3D accelerometer data was converted to activity counts using the Actigra-











































































Figure 5.3: Number of events for each participant. y axis shows the number of
events and x axis shows the unique IDs. Compensated and decompensated events
are shown with different colors.
In the first step, the z-axis of the accelerometer data was filtered using a band-
pass Butterworth filter with 0.25− 11 Hz passband to eliminate extremely slow
or fast movements [131]. Then, the maximum values inside 1-second windows
were summed for each 30-second epoch to obtain the activity counts, following
the approach described by Borazio et al. [98]. Figure 5.4 illustrates the double plot
for the motion data for one participant over a recording period of 300 days. White
regions indicate missing data, which could be due to the participant turning off
the data sharing or the smartphone running out of battery.
Social contact data included the call data and the duration of each call. Each
contact was anonymized and assigned a unique identifier at the source. Fig-
ure 5.5 illustrates one participant’s social contact over 300 days for the ten most
frequently contacted IDs. Lastly, location data was collected using the Android
location services application program interface, which generally used cellphone
tower or WiFi and not GPS for geolocation. Figure 5.6 shows the location data of
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Figure 5.4: Double plot representation of smartphone actigraphy data, which
illustrates daily motion intensity levels for one participant. Darker colors indicate
lower intensity movement, and the white color indicates missing data. On the top
of the plot, decompensated and compensated clinical events are shown with red
and orange squares respectively.
a participant, collected from compensated and decompensated windows. High
spatial resolution was not required since the aim was to identify the general en-
vironment in which a user was located. (E.g., home, work, shops, etc.) If the
smartphone moved at least 100 meters, and at least 5 minutes had passed since
the last location data update, a new relative location was recorded. These pa-
rameters were defined while designing the app to preserve battery life while still
providing sufficient temporal and spatial resolution in comparison to the phone’s
ability to geo-locate without GPS.
Active data sources
Active data type, which required user input, was KCCQ administrated through
the smartphone app. The scores are lower for severe HF symptoms, and KCCQ
scores ≤ 25 correspond to New York Heart Association (NYHA) class IV. In this
study, we used the shorter version of the questionnaire, referred to as KCCQ-12
[132]. The KCCQ-12 survey had physical limitation, symptom frequency, qual-
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Figure 5.5: Participant’s social contact intensity over 300 days. Each unique con-
tact is assigned a number as shown in the y-axis, and the circle radius is pro-
portional to call duration to each ID. On the top of the plot, decompensated and
compensated clinical events are shown with red and orange squares respectively.
Figure 5.6: Location data collected in compensated and decompensated windows,
shown on the same map with 50x50 km dimensions.
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ity of life, and social limitation domains, and the summary score (ranging from
0-100) was the average of all domains. Figure 5.7 shows the KCCQ-12 scores
administrated through the app.
Figure 5.7: KCCQ summary score over days for one participant. KCCQ score ≤ 25
indicates a transition to severe HF. On the top of the plot, decompensated and
compensated clinical events are shown with red and orange squares respectively.
5.1.2 Personalized prediction models of heart failure severity
In the preliminary analysis conducted in 2018, the feasibility of predicting the
quality of life of patients with HF using passive smartphone data measured via
the smartphone app was assessed [64]. Patient-specific models to estimate KCCQ
using various features from past passively monitored data were built. In a sub-
sequent analysis, these features were used to cluster patients into high (KCCQ ≤
25) versus moderate (KCCQ > 25) severity HF groups.
Feature extraction
Several features were extracted from movement data to evaluate rest-activity char-
acteristics and circadian rhythms of subjects. Rest-activity rhythms were assessed
using IS, IV, Most Active 10 Hours (M10), and Least Active 5 Hours (L5) [124].
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IS and IV were described in detail in subsection 4.1.3. M10 is the average of the
most active 10 hours over all days. A drop in M10 could imply a reduction in
physical activity due to HF symptoms. Lastly, L5 is the average of the least active
5 hours. L5 indicates movements during sleep, and night-time arousal. Cosi-
nor rhythmometry features, total energy of activity data, and the time of day of
the maximum activity rhythm were also calculated. The correlation coefficient
Rk quantifies the correlation of a variable with itself at a previous time, e.g. Ai
versus Ai−k. In this work a lag k = 24 hours was used. A more pronounced
circadian rhythm will result in a higher Rk [133]. MSE was calculated to quantify
irregularity or unpredictability of behavior over multiple timescales. MSE was
calculated following the methods described by Costa et al. [134]. Actigraphy time
series were coarse-grained by averaging the data points within non-overlapping
windows. The first 20 scales of multiscale entropy were calculated by varying the
window size from 1 to 20. For each coarse-grained time series, sample entropy
was calculated.
Severe HF causes discomfort and can hinder physical activity, which could
lead to the subject staying at home more, or altering routine behaviors. Location
features were extracted to capture these changes. Using all location data from
each subject, the “home” location was defined as the most frequently visited lo-
cation. The percentage of time spent at “home” was calculated. The second most
frequently visited location was determined in a similar fashion as “home”. The
percentage of time spent at the second most frequent location was calculated.The
area within a 20 km radius from home was designated as “zone-1”, and the area
outside of this radius was called “zone-2”, as shown in Figure 5.8. The number
of times the subject visited each zone was counted.Haversine distances between
all locations to the “home” location were summed. The Haversine distance is the
shortest distance between two coordinates over the surface of the earth.
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Figure 5.8: Example of location data collected with AMoSS app. Increasing height,
represents the probability of visiting an area. Areas south and west from the
origin are represented as negative distances. The red circle is the boundary of
“zone-1”, the area enclosed by a circle of 20 km radius from most frequently
visited location.
HF symptoms could affect a subject’s social behavior. The following contact ac-
tivity features were extracted from smartphone data: total number of calls, mean
duration of calls, standard deviation (std) of duration of calls, mean duration
without any calls, standard deviation of duration without any calls.
Machine learning models
Personalized models were created for each subject to estimate the KCCQ sum-
mary score. GLM with binomial distribution and logit link was used. Elastic net
regularization was applied to personalized GLMs to decrease bias and improve
classification performance [135]. Models were built only for subjects from whom
sufficient data was gathered over at least ten windows at that time of the study,
and a window was defined as two weeks. If insufficient data was gathered from
ten or more windows, or did not share a specific data type at all, no model was
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built for that data type.
Model performance was assessed via record-wise leave-one-out cross valida-
tion (LOOCV). Given N windows of data, N − 1 windows are used to train the
model for a given patient for predicting KCCQ scores, and the held-out window is
used as the test set data from which a KCCQ score is predicted. This is repeated
for the remaining N − 1 windows. The Mean Absolute Error (MAE) between
actual and estimated KCCQ scores was calculated for each personalized model.
In addition to regression analysis, a classification analysis with a K-Nearest
Neighbors (K-NN) approach was performed after quantizing KCCQ summary
scores. Data were dichotomized into KCCQ scores ≤ 25 or > 25 [136]. KCCQ
scores ≤ 25 correspond to New York Heart Association (NYHA) class IV. Patients
with class IV HF are unable to complete any physical activity without discomfort.
KCCQ scores > 25 correspond to NYHA class I-III which describes less severe
HF compared to class IV. Clustering analysis was performed for two subjects
who had enough KCCQ summary scores in each class. Cosine distance and five
nearest neighbors were used as model specifications. Five-fold cross validation
was implemented whereby the model was trained on four folds and the fifth held-
out fold was used for testing, and this process was repeated for the remaining four
folds. The percentage of correctly classified points were reported for each subject.
Experimental results
The average MAE over the population for estimating the KCCQ using only activ-
ity metrics was 5.71 units (or percent, since the scale is normalized to be between
0-100) as shown in Table 5.1. When only location metrics were used to estimate
the KCCQ scores, the MAE rose to 7.40 (N=8). For personalized models based on
contact activity features, the population average (N=9) MAE was 6.05. For per-
sonalized models built with features from all three data domains, the population
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average MAE was 5.43. Although one might therefore be tempted to infer that
movement provides the most information in this context, inspection of Table 5.1
shows that the most useful type of data depends on the individual. Moreover,
the most frequently selected features by elastic net in the LOOCV procedure also
varied according to the subject. This creates a strong case for personal models
trained on initial KCCQ reports. It can also be noted that the models developed
here outperform the baseline (sample-and-hold) estimate, i.e. simply using the
first KCCQ score. No error exceeded 8% when all three domains of data types
were available.
Table 5.1: Mean absolute error of leave-one-out cross validation KCCQ estimation
models for each of the first 10 patients in the AMoSS HF dataset.
Initial KCCQ Motion Location Social contact Combined Baseline
score features features features features model
95 0.43 0.90 0.91 0.44 2.12
50 † 2.26 2.47 2.25 40.39
13 4.93 † 4.01 3.92 4.74
56 5.45 7.73 6.44 5.45 34.86
71 5.46 5.44 5.68 5.49 6.61
38 7.50 12.08 7.41 7.52 17.96
77 9.41 9.55 7.82 7.85 19.87
19 † 12.32 8.82 7.99 6.10
13 8.22 8.31 † 8.33 19.31
33 † † 10.90 † 13.32
AVG→ 5.71 7.40 6.05 5.43 16.53
† indicates patient did not share data type.
Figure 5.9 provides a visualization of points with t-Distributed Stochastic Neigh-
bor Embedding [137] in 3 dimensions using social contact features. Using contact
activity features from two subjects (Subject 1 and Subject 8 from Table 5.1), five-
fold cross validation of the K-NN classification approach was performed. Out-of-
sample classification accuracy for these two subjects were 0.78 and 0.88 respec-
tively. Repeating the same analysis with location features resulted in respective
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Figure 5.9: Visualization of two KCCQ clusters (Severe HF defined as KCCQ≤ 25)
in three arbitrary dimensions (represented by t1−3) using t-Distributed Stochastic
Neighbor Embedding on social networking behavior features for two subjects.
5.1.3 Dynamics of interpersonal social interactions and motion passively captured
from smartphones predicts decompensation in heart failure
In the second analysis using AMoSS HF dataset, motion, social, location, and
clinical survey data collected via the smartphone-based monitoring system were
used to develop and validate an algorithm for predicting or classifying HF decom-
pensation events (hospitalizations or clinic visit) versus clinic monitoring visits in
which they were determined to be compensated or stable. Models based on single
modality as well as early and late fusion approaches combining patient-reported
outcomes and passive smartphone data were evaluated. Passively collected data
from smartphones, especially when combined with weekly patient-reported out-
comes, may reflect behavioral and physiological changes due to HF and thus
could enable prediction of HF decompensation.
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Feature extraction
Several features were extracted from the data collected through the app to con-
struct the motion feature set. A window of data was the N day period be-
fore a clinical event, and the feature extraction was performed for each win-
dow. The window size N was chosen to be 14 days initially since it was also se-
lected by the developers of KCCQ to represent the participant’s recent functioning
[61]. Firstly, from preprocessed smartphone activity counts, descriptive statistics
were extracted. These included mean (actmean), standard deviation (actstd), mode
(actmode), skewness (actskew), and kurtosis (actkurt). The completeness percentage
(actcomp) was calculated by dividing the epochs with data by the total number of
epochs in the window.
For each window, the total number of calls (numCalls), the sum of the duration
of calls (durCalls), the standard deviation of the duration of calls (durCallsstd),
the sum of durations without any calls (durNoCalls), and the standard deviation
of these durations (durNoCallsstd) were calculated to be used as social contact
features.
Using the participant’s location data, the most frequently visited location was
determined and defined as the “home” location. The number of times the partici-
pant was at the home location was calculated and used as a feature (atHome). For
the second location feature, Haversine distances between all locations to the home
location were summed (distToHome). Lastly, the area within a 2 km radius from
home was defined as “zone-1”. The area outside of this radius was defined as
“zone-2”. The number of times the participant contributed from these two zones
were calculated (zone1, zone2).
From the KCCQ data, two different feature sets were investigated. Firstly, the
summation score (KCCQsum) was used as a feature. For the second set (KCCQall),
each domain (physical limitation, symptom frequency, quality of life, and social
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limitation) was used separately. For these two active data feature sets, the per-
formance of using the mean of all surveys inside the window or using the most
recent survey was also tested.
Machine learning models
Logistic regression classifiers were trained to map the feature vector to the com-
pensated or decompensated outcome. All the models were written in the Python
3 language, and the programming code was based on Scikit-learn [113]. Since
each participant could contribute more than one event, we used leave-one-patient
out cross-validation. The model was trained on the data from all participants ex-
cept one held-out participant, and this participant’s data was used as the test set.
This process was repeated for each participant in the dataset. All experiments
were repeated 50 times to obtain the final results.
Since the number of compensated and decompensated events were highly im-
balanced, as seen in Table 2.2, the majority undersampling was performed on
the training set before training the classifiers. During the majority undersam-
pling, all participants from the minority class were used, and the same number of
participants from the majority class were randomly selected. Sequential forward
feature selection was used to select the three most informative features from each
modality.
Early and late fusion approaches combined passive and active modalities and
are shown in Figure 5.10. In the early fusion approach, extracted features were
combined at the input level to create a single feature vector. Secondly, all single
modality model’s output probabilities were concatenated and used as input to an-
other classifier for the late fusion approach. In the fusion models, the participants
who contributed all data types were included in the analysis. Models were also
evaluated on the same participants to analyze if the fusion approached improve
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upon the single modality approaches. Finally, the effect of changing the window
size and sliding the window was tested using the same participants for all the
models.
Model performance metrics were accuracy (Acc.), Positive predictive value
(PPV), True positive rate (TPR), AUC, and Area under the precision-recall curve
(AUCPr). In this analysis, positive class was the decompensated events while
compensated events were the negative class. Accuracy is the ratio of the number
of correctly classified samples to the total number of samples. PPV (or precision)
is the ratio of the number of correctly classified positive samples to the number of
the samples which is predicted as positive. TPR (or recall) is the ratio of positives
that are correctly classified to actually positive samples. AUC is the area under
the ROC curve which shows the model performance under different classification
thresholds. Lastly, AUCPr is the area under precision-recall curve.
Figure 5.10: Modality fusion techniques. Purple and red colors indicate two dif-
ferent modalities. Figure (a) shows the early fusion approach, and figure (b)
shows the late fusion of the modalities.
To examine and interpret the features further, SHapley Additive exPlanation
(SHAP) values for the early fusion model were calculated [138]. This framework
is model agnostic, and SHAP values quantify the contribution and impact of each
feature to the model.
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Experimental results
The cross-validation performance for each single modality model is shown on
Table 5.2. For these experiments, the window was set to 14 days before each clin-
ical event. The number of unique participants and the number of clinical events
changed according to the modality since the participants could stop contributing
data. For the motion model, 23 participants contributed 28 decompensated events
and 44 compensated events. For the social contact model, there were 21 partic-
ipants with 27 decompensated events and 45 compensated events. Lastly, there
were 18 participants with 13 decompensated events and 33 compensated events
for the location model.
Table 5.2: Passive data model performances. Results are reported as
mean(standard deviation) of the external folds of each experiment.
Modality Acc. AUC AUCPr PPV TPR
Motion 0.66 (0.03) 0.66 (0.03) 0.60 (0.06) 0.55 (0.04) 0.61 (0.06)
Location 0.59 (0.07) 0.56 (0.10) 0.39 (0.11) 0.34 (0.10) 0.49 (0.17)
Social 0.58 (0.05) 0.65 (0.05) 0.56 (0.06) 0.46 (0.06) 0.60 (0.07)
Table 5.3 provides the single modality results for the active data type, KCCQ
survey. For two different feature sets (KCCQsum and KCCQall), the table shows
the performance metrics when the mean of all the questionnaires within the 14-
day window was used and when the most recent questionnaire was used. For
this active data type, 20 unique IDs contributed 23 decompensated events and 32
compensated events. Using the summary KCCQ score and taking the most recent
questionnaire has resulted in the highest AUCPr score of 0.69.
In the fusion of KCCQ and motion data, 15 participants contributed 13 de-
compensated events and 27 compensated events. Similarly, for KCCQ and mo-
tion data model, 17 participants contributed data for both modalities, 21 decom-
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Table 5.3: Active data single modality model performance. Results are reported
as mean(standard deviation) of the external folds of each experiment.
Modality Acc. AUC AUCPr PPV TPR
Mean of window,
KCCQsum
0.64 (0.01) 0.75 (0.01) 0.61 (0.02) 0.55 (0.01) 0.66 (0.03)
Mean of window,
KCCQall
0.65 (0.02) 0.67 (0.02) 0.54 (0.04) 0.57 (0.02) 0.69 (0.04)
Most recent,
KCCQsum
0.69 (0.01) 0.77 (0.01) 0.69 (0.02) 0.61 (0.02) 0.71 (0.03)
Most recent,
KCCQall
0.69 (0.03) 0.70 (0.01) 0.61 (0.04) 0.60 (0.02) 0.74 (0.04)
pensated events, and 26 compensated events. When three modalities were used
(KCCQ, motion, social contact), 16 participants contributed 18 decompensated
events and 21 compensated events. Lastly, when all data types were merged,
there was data available for 12 participants, ten decompensated events, and 18
compensated events. The results for the early fusion models is shown in Ta-
ble 5.4 and in Table 5.5 for the late fusion models. The highest AUCPr of 0.77 was
achieved when KCCQ and motion and social contact modalities were combined
with late fusion. For early fusion models, using the same modalities resulted in
an AUCPr of 0.69. The corresponding SHAP summary plot for the early fusion
model is shown in Figure 5.11.
Using the best models in each category, how early the algorithm could pre-
dict the outcome (time-to-event analysis) was also investigated. In this analysis,
participants who shared data for all windows and data types were used (N=13;
13 decompensation events; 18 compensation events). Figure 5.12 illustrates the
AUCPr of the models as the window was shifted. From the single modality mod-
els, social contact model was most drastically effected by shifting the analysis
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Table 5.4: Results of early fusion models. Results are reported as mean(standard
deviation) of the external folds of each experiment.
Modality Acc. AUC AUCPr PPV TPR
Motion, soc. 0.62 (0.04) 0.58 (0.03) 0.54 (0.04) 0.53 (0.05) 0.53 (0.06)
KCCQ, motion 0.73 (0.02) 0.81 (0.01) 0.75 (0.03) 0.69 (0.02) 0.73 (0.05)
KCCQ,
motion, soc.
0.71 (0.04) 0.72 (0.05) 0.69 (0.06) 0.70 (0.04) 0.66 (0.09)
KCCQ, motion,
soc., loc.
0.67 (0.05) 0.64 (0.07) 0.57 (0.11) 0.55 (0.07) 0.56 (0.09)
Table 5.5: Results of late fusion models. Results are reported as mean(standard
deviation) of the external folds of each experiment.
Modality Acc. AUC AUCPr PPV TPR
Motion, soc. 0.64 (0.03) 0.63 (0.04) 0.52 (0.05) 0.54 (0.04) 0.56 (0.07)
KCCQ, motion 0.67 (0.03) 0.75 (0.02) 0.67 (0.04) 0.61 (0.03) 0.72 (0.07)
KCCQ,
motion, soc.
0.71 (0.04) 0.79 (0.03) 0.77 (0.04) 0.68 (0.04) 0.70 (0.05)
KCCQ, motion,
soc., loc.
0.62 (0.07) 0.72 (0.07) 0.60 (0.11) 0.49 (0.07) 0.68 (0.10)
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Figure 5.11: SHAP summary plot for the early fusion model. Features are sorted
by their impact on the y-axis. Each point on the plot shows the Shapley value for
one instance. Horizontal location shows the feature’s effect for predicting positive
class (decompensated) or negative class (compensated), and color indicates the
feature value.
window. Late fusion models performed better compared to KCCQ models when
time to event was less than four days. Figure 5.13 shows the effect of the win-
dow size to AUC and AUCPr metrics. Similar to time-to-event analysis, only the
participants who shared all data types for all windows were used (N=11; 12 de-
compensation events; 15 compensation events). It can be seen that KCCQ model
performance was not effected, since this model used the last score (closest to the
event) within the window. Social contact model’s performance was improved as
the window size was decreased.
5.2 Using movement data for chronic post-traumatic stress disorder state esti-
mation
Using the Actiwatch research watch data from the Emory PTSD dataset described
in subsection 2.6.1, movement features (IS, IV, mean and standard deviation of
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Figure 5.12: Performance change as the data window is shifted. x axis indicates
the time-to-event. Early and late fusion models use KCCQ, motion, social contact
modalities.
Figure 5.13: Performance change as the data window size is changed. x axis
indicates the window size. Early and late fusion models use KCCQ, motion,
social contact modalities.
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movement, CRSµ, CRSσ, RSIµ, RSIσ, Mesorµ, Mesorσ, Amplitudeµ, Amplitudeσ,
Phaseµ, Phaseσ) were derived. From the participants who wore the Actiwatch,
there were N = 8 participants who were diagnosed with long-term PTSD and
there were N = 88. Due to low number of PTSD participants, it was not possible
to build a cross-validated classifier. T-test was used to compare the means of
features for PTSD and non-PTSD groups. Among these 14 movement features,
CRSσ and IS features had statistically significant difference (p = 0.028 and p =
0.017 respectively). Figure 5.14 illustrates the violin plots of IS and CRSσ for both
groups.
Figure 5.14: Violin plots of motion features IS and CRSσ motion features.
5.3 Use of a wearable device to assess sleep and motor function in Duchenne
muscular dystrophy
In another study, actigraphy data was used to assess the sleep disturbance and
day-time activity levels in participants with DMD [139]. A subset of the ambu-
latory participants (N=13) completed 6-minute walk test (6MWT) during their
appointments to assess their functional capacity. The 6MWT measures how far
an individual can walk within a 6-minute period and was conducted with am-
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bulatory participants in accordance with the methods described in 2010 by Mac-
Donald et al. [140]. The percentage predicted 6-minute walk distance (6MWD)
was calculated by dividing the distance walked by the expected distance for each
participant’s age and height by using the Geiger equation [141]. Parents of all
participants completed the Sleep Disturbance Scale for Children [142]. The ques-
tionnaire consists of 26 Likert-type questions and one of the factors measured was
Disorders of Initiating and Maintaining Sleep (DIMS).
A longitudinal actigraphy dataset was created using the Actiwatch research
watch, as described in subsection 2.6.4. The rest/activity metrics (IS, IV, M10,
L5) were derived from the research watch actigraphy data of the participants
following the steps described in subsection 4.1.3. For the ambulatory group, lin-
ear regression models were built to assess the associations of outcomes with the
metrics. Within the ambulatory group, linear regression modeling revealed a
significant association between M10 and percentage predicted 6MWD such that
more daytime activity was associated with better 6MWD performance (R2 =
0.41, p = 0.019). In addition, a more fragmented daily rhythm (higher IV) had
more difficulty initiating and maintaining sleep as measured by the DIMS sub-
scale (R2 = 0.61, p = 0.008).
5.4 Discussion
In the first project described in this chapter, features derived from data passively
collected by a smartphone app were used for predicting decompensation events
in a heart failure population. There were three passive data modalities (motion,
location, and social contact) and one active (the KCCQ). The hypothesis was that
activity, location, and social contact data were all affected by changes in health sta-
tus for patients with HF, and these data gathered via smartphone could be used
to assess patient quality of life. Activity data can be used to infer the circadian
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rhythm of the patient, activity-rest schedules, and disruptions (such as awaken-
ings during the night). Location data can indicate if the patient is disinclined or
unable to leave the house or continue a normal routine. Social contact data pro-
vides information about the patient’s social interaction, particularly with a given
subgroup of contacts. During health changes, we observe a change in social be-
havior with a user changing the frequency or duration of calls and to whom they
are placed. Although none of these changes are particularly specific to changes in
HF when taken in isolation, when combined, they provide a more accurate mea-
sure of the changes in health. For this dataset, traditional change point detection
methods are not feasible for detecting decompensation events since the data is
unstructured and the missingness is high.
In the first sub-project, features extracted from the three domains (activity, lo-
cation, and social contact) were used to build personalized models to estimate the
quality of life-related to HF. Personalized models were implemented instead of
population models because KCCQ scores are subjective and self-reported. Using
only activity data, the MAE in the KCCQ estimate was 5.71%. A K-NN model,
which classifies KCCQ scores as ≤ 25 or > 25 was implemented to detect clin-
ically significant changes in the population. This binary classifier exhibited an
accuracy of 78% and 88% for the two subjects who had a sufficient number of
passive data and KCCQ scores.
Using only passive data sources, as described in this analysis, and eliminating
active data uploading can reduce the burden on patients by minimizing their ef-
fort required to participate and increase adherence to monitoring. Moreover, the
phone app provides a natural communication medium for the caregiver to inter-
vene when significant or sustained deterioration in health is detected. Subjects
had the option to determine which types of data to share and the frequency of
their uploads. This option was provided to empower users to take ownership of
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their data, decide when and how they were monitored, and increase compliance.
For patients with high mortality risk, these options could be removed to improve
data continuity and adherence. It is important to note that patients’ adherence to
uploading of active data sources can decline rapidly over time [143].
We also observed variation in compliance measured by active data upload-
ing, but this was not a consistently diminishing level as implied in other studies.
For example, a subject enrolled for 428 days sent passive activity data for 328
days, although only 46 KCCQ survey reports were completed in the same period.
However, we may only need the first few weeks of reports to build individual-
ized models during the higher compliance period. In the cases where we have
insufficient data to build a model, or the confidence in the model drops below a
given threshold, incentives can be provided to report the KCCQ. In this way, the
information is maximized, and the patient burden is minimized.
In the second sub-project, next-day HF decompensation prediction algorithms
were built using each modality separately and fusing all data types. From the
passive data sources, the motion data-based model achieved the highest AUCPr
of 0.60. For a model based only on the responses of the KCCQ, using the sum-
mary of all domains and using the most recent score resulted in the best perfor-
mance with an AUCPr of 0.69 (Table 5.3). Combining both passive and active
data modalities achieved a superior performance compared to models based on
passive or actively collected data alone (see Table 5.4 and Table 5.5). The highest
performing model combined KCCQ, motion, and social contact data. Late fusion
approach achieved a 8% higher AUCPr than early fusion when three modalities
were used. Late fusion presents a lower-dimensional vector to the final classifier
[144]. Therefore, this method could reduce the chances of overfitting and ad-
dresses the curse of dimensionality when the sample size is small. The TPR (0.70)
and PPV (0.68) of this model could indicate that the approach could potentially
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add clinical interventions into the framework and result in a low number of false
alarms.
Figure 5.11 illustrates the feature importance using the SHAP method. Dura-
tion and number of calls were among the most informative features, indicating
that the dynamics of social interactions could be affected by the disease status.
It can also be seen in the SHAP summary plot that a higher call duration but
fewer number of calls result in a higher probability of HF decompensation. An-
other important feature was the KCCQ summary value, and a lower value of this
parameter gave rise to higher SHAP values. The SHAP plot also indicated that
higher mean smartphone motion intensity resulted in a higher probability of HF,
which was unexpected since HF limits daily physical activity and is often asso-
ciated with fatigue. In a previous study, Duncan et al. have shown that steps
measured by a smartphone and a wearable differed a mean bias of 21.5%, and
hypothesize that this could result from the behavior of the participants (i.e., not
carrying the phone on short walking breaks, carry location for the phone) [145].
Similarly, our results show that the smartphone’s motion data does not measure
the physical effort but that it reflects patterns of behavior, including phone uti-
lization and body movements.
When different time-to-event horizons were tested, a general trend of lower
performance for longer future predictions was observed, as expected, since symp-
toms are likely to become more pronounced closer to the event. However, pre-
dictions two days ahead were better than one day, and performance four days
ahead was almost as good as one day before the event. This indicates that one-
day, two-day, and four-day models could be run simultaneously to identify short-
and medium-term risks and result in different levels of intervention. Changes in
performance will be affected by the levels of missingness as the event approached
and the intrinsic behaviors, which may explain the performance of the two-day
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window.
There are two fundamental limitations of the analysis on this project. Firstly,
when the data were missing, the app did not indicate whether this resulted from
the participant closing the app voluntarily or if it resulted from the smartphone
battery running out. These behaviors have different etiologies, which may be
related to impending decompensation in different ways. For example, closing
the app may indicate being tired, whereas a battery running out of charge may
indicate apathy connected with depression. If an additional label is collected for
missing sections, it could be used to learn other behavioral patterns. Secondly,
even though each participant contributed many days, the study’s sample size was
relatively small (N=28 participants), and therefore, the methods should be further
validated in a larger cohort.
Finally, motion data collected with wearables were investigated for chronic
DMD and PTSD cohorts. While cross-validated models could not be built due
to small set of data samples, the motion features were compared with clinical
outcomes. DMD study indicated that wearable-based approaches could provide
an opportunity to monitor DMD patients non-invasively. First, ambulatory par-
ticipants with more activity rhythm fragmentation had higher ratings of subjec-
tive impairment in initiating and maintaining sleep. IV and the DIMS subscale
measure overlapping constructs of sleep disruption, and their close association
provides evidence that IV is a clinically meaningful indicator of sleep-wake dys-
function in DMD. Second, habitual day-time activity was associated with walk
test performance, providing evidence that M10 may be a valid marker of ambula-
tory status complementary to the 6MWT. Similarly, in the Emory PTSD dataset, IS
and CRSσ features were statistically significant across healthy and chronic PTSD
groups. PTSD group had lower IS, which could indicate that this group had
lower coupling to environmental zeitgebers that regulate the circadian rhythm.
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This group also had a higher and more variant CRSσ feature. Further data collec-
tion is required for both of these studies, but the findings in this dissertation could
indicate that wearable-based approaches could be useful for passive monitoring
at home.
5.5 Conclusion
In this chapter, machine learning approaches for monitoring chronic state HF,
DMD, and PTSD patients were introduced. Chronic diseases persist over longer
periods [129], and could require long-term care to improve the recurring symp-
toms. Thus, the methods described in this dissertation could be beneficial for
patients suffering from chronic conditions and their care providers. Firstly, due to
the ubiquity of smartphones or wearables and the ease of scalability of the frame-
work, these methods will facilitate monitoring large populations at a low cost.
Secondly, they could be considered minimally invasive and impose less burden
on patients already suffering from long-term diseases. In conclusion, the findings
from this chapter demonstrate the feasibility of wearable and smartphone-based
approaches to monitor chronic diseases and show that these methods could be




This dissertation presents wearable-based tools and technologies for improving
longitudinal patient monitoring. The overall aim of the dissertation is to present
low-cost and non-invasive technology that can be combined with existing tools
for more accurate and efficient longitudinal monitoring. All the methods pre-
sented in this work are validated using large-scale human-subject studies with
data collected in the wild.
The first part of this dissertation focused on building a novel sleep detection
model using the physiological and motion signals and discussed how the change
points in these signals could be utilized to estimate underlying sleep/wake states.
This work demonstrated that only the information in the change points is suffi-
cient to achieve unbiased performance. Storing the signals as change-event time
series could reduce the required memory of the device. In this way, this work
would enable the memory-constraint wearables to monitor longer durations in-
home settings. Furthermore, different smartwatch brands could provide signals
with varying amplitudes, but the proposed method was dependent only on the
changes in the signals, so it could be well-suited to work on any device.
In the second part of the dissertation, longitudinal wearable-based monitoring
techniques are presented for two different applications. The first work showed
that these features that quantify the physiological variability in the weeks post-
trauma could provide important information regarding the health conditions in
the following months. While the wearable-based models were not very useful
for estimating PCL-5 survey outcome, the models showed better performance
for distinguishing between healthy participants and participants with multiple
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symptoms. Furthermore, it is shown that including the wearable-based monitor-
ing could improve upon self-report surveys administrated in ED and could be
more helpful in identifying changes in the disease status.
The last part of the dissertation discussed using wearables to monitor partic-
ipants with chronic health conditions such as heart failure. A smartphone-based
framework collected passive and active data types from participants. Novel algo-
rithms were developed for predicting decompensation events, and the predictive
performance of each data modality was tested. To the author’s knowledge, this
work represents the first smartphone-based approach for non-invasive longitu-
dinal monitoring for cardiovascular diseases. Fusion approaches for combining
all modalities were evaluated and discussed. Most significantly, it is shown that
the inclusion of passive metrics improved the performance, and therefore, this
approach could improve upon self-report-based methods for monitoring heart
failure patients.
Although the passive-monitoring models developed in this dissertation have
shown promise in detecting both developing and chronic health conditions, fu-
ture studies are required for assessing if they could be coupled with clinical in-
terventions and if they could be deployed on wearable devices to be used during
free-living conditions. Possible future directions and improvements could include
(i) detecting non-wear regions from wearables and handling the missing data, (ii)
investigating circadian variability of the heart rate for mental health disorders,
(iii) alerting caregivers using disease severity estimates from the models. In the




6.1.1 Detecting non-wear regions from wearables and handling the missing data
Non-wear periods are recordings of data when the participant does not wear the
device, but data is recorded and not marked as missing. These non-wear regions
could be confused with sedentary periods and could lead to biases in circadian
metrics and inaccuracies for sleep-period detection. A new dataset should be
created to validate algorithms for non-wear region detection since none of the
datasets used in this dissertation had labels for this task. Existing approaches in
the literature focus on the tilt and the activity intensity measured by accelerometer
signals [146, 147], the signal quality of the PPG signal or the number of heartbeats
detected in the window could also be used as additional tools. After the non-
wear periods are detected, these could also be marked as missing data regions.
Performance of different missing data imputation techniques could be tested to
see the effect on the final model performance.
6.1.2 Investigating circadian variability of the heart rate for mental health disorders
HPA axis and the master biological clock SCN regulate the cortisol hormone re-
lease to the body through complex biological pathways [148]. Cortisol production
also follows a rhythm under the control of these systems, rising before sleep offset
and decreasing through the day. Previous studies have shown that patients with
mental health could have abnormal cortisol rhythms, with phase advancements
[148, 149]. Since cortisol leads to an increase in the heart rate, the metrics derived
from the PPG data could track this rhythm. Other HRV metrics such as LF, HF,
or RMSSD could also be monitored daily to quantify the stress response through
HRV. It was not possible to monitor the circadian variability of the heart rate in
this dissertation due to the high missingness of the data during daytime as shown
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in Figure 4.3. If another wearable is used to collect higher quality PPG data from
both daytime and sedentary regions, circadian variability of the heart rate could
become another biomarker to monitor the participants.
6.1.3 Alerting caregivers using disease severity estimates from the models
Finally, the methods developed in this dissertation could be coupled with clinical
interventions. The model’s output could be interpreted as a severity indicator
instead of class membership and the framework could alert the caregiver if there
is a deterioration. For example, for the AMoSS project, the models could be de-
ployed on smartphones, and the app could deliver alerts to the clinical teams.
Based on this, the clinicians could check their patients and deliver timely support
and corrective therapies. However, whether this approach could reduce hospital-
izations and improve patient’s quality of life should be tested in real-life scenarios
and further validated.
6.2 Final remarks
Recent advances in wearable technology provided a new tracking tools for re-
searchers. The methods described in this dissertation could significantly improve
passive wearable-based monitoring and provide insights to patient’s daily life be-
haviours outside the clinic. Sleep diaries could be used to find the sleep periods
of patients and then CPD method could be used to objectively track sleep dis-
turbances every night. Biological rhythm metrics from wearables or smartphones
could track the patient’s recovery after hospital discharge. This dissertation pro-
vides a basis for a non-invasive health monitoring on multiple scales and these
technological advances could become a complementary tool for clinicians.
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